University of South Florida

Digital Commons @ University of South Florida
Graduate Theses and Dissertations

Graduate School

11-15-2010

Chromatin Unfolding by Cdt1 Regulates MCM Loading via
Opposing Functions of HBO1 and HDAC11-Geminin
Philip G. Wong
University of South Florida

Follow this and additional works at: https://digitalcommons.usf.edu/etd
Part of the American Studies Commons

Scholar Commons Citation
Wong, Philip G., "Chromatin Unfolding by Cdt1 Regulates MCM Loading via Opposing Functions of HBO1
and HDAC11-Geminin" (2010). Graduate Theses and Dissertations.
https://digitalcommons.usf.edu/etd/3696

This Dissertation is brought to you for free and open access by the Graduate School at Digital Commons @
University of South Florida. It has been accepted for inclusion in Graduate Theses and Dissertations by an
authorized administrator of Digital Commons @ University of South Florida. For more information, please contact
scholarcommons@usf.edu.

Chromatin Unfolding by Cdt1 Regulates MCM Loading
via Opposing Functions of HBO1 and HDAC11-Geminin

by

Philip G. Wong

A dissertation submitted in partial fulfillment
of the requirements for the degree of
Doctor of Philosophy
Department of Cancer Biology
College of Arts and Sciences
University of South Florida

Major Professor: Mark G. Alexandrow, Ph.D.
Lori A. Hazlehurst, Ph.D.
Gary W. Reuther, Ph.D.
Edward Seto, Ph.D.

Date of Approval:
November 15, 2010

Keywords: Cdt1, HDAC11, HBO1, chromatin, DNA replication
Copyright © 2010, Philip G. Wong

DEDICATION

To my mother, Ming Hsieh
and my father, Quon Wong

And to my wife,
Nancy Parquet

ACKNOWLEDGEMENTS

I would first like to thank Dr. Mark Alexandrow for his mentorship and guidance.
I am grateful that he has put forth the effort to teach me what it means to become a
scientist and I feel extremely fortunate to have been a member of his lab.
I wish to express my gratitude to the members of my committee, Dr. Lori
Hazlehurst, Dr. Gary Reuther, and Dr. Edward Seto. Over the years they have taken it
upon themselves to provide many valuable suggestions and advice to help further my
research. I would also like to thank Dr. Cyrus Vaziri for taking the time to serve as the
external chair for my dissertation defense committee.
I thank the Cancer Biology Program for giving me the opportunity to pursue my
doctoral training and providing an outstanding educational environment. The members
of my lab, past and present, have helped me a great deal and I owe them my gratitude.
Finally, I owe my greatest thanks to my family and friends. I thank my parents
for their continual support and love and I am grateful for the laughter BCP and HJW have
brought me.

I am forever indebted to Nancy Parquet for being a constant source of

inspiration and encouragement, without her I would not have been able to complete this
dissertation.

TABLE OF CONTENTS
LIST OF TABLES

iii

LIST OF FIGURES

iv

LIST OF ABBREVIATIONS

vii

ABSTRACT

ix

CHAPTER 1: INTRODUCTION
Cancer
Genomic Instability in Cancer
Loss of Proliferation Control
Cell Cycle
DNA Replication
Origin Recognition Complex
Cdc6
Cdt1
MCM Complex
Pre-Replication Complex Quantification
Chromatin
Histone Acetyltransferases
HBO1
Histone Deacetylases
Class I HDACs
Class II HDACs
Class III HDACs
Class IV HDAC: HDAC11
Chromatin Remodeling in DNA Replication

1
1
2
3
4
6
13
14
15
19
20
21
23
25
26
28
29
30
31
32

CHAPTER 2: MATERIALS AND METHODS
Cell Culture
Transfections
Antibodies
Plasmids and cDNAs
Protein Chemistry

36
36
36
37
37
38

i

Immunofluorescence
Flow Cytometry
ChIP Assays and qPCR
DNase I Accessibility Assays

39
40
40
42

CHAPTER 3: RESULTS
HDAC11 Associates with Replication Origins, Inhibits Cdt1-Induced
Re-Replication and Suppresses MCM Loading
Geminin Facilitates the Binding of HDAC11 to Cdt1
Cdt1 Targeting Induces Large-Scale Chromatin Decondensation
Cdt1-Induced Chromatin Unfolding Occurs During G1
Geminin Efficiently and Specifically Suppresses Cdt1-Induced
Chromatin Unfolding
Chromatin Unfolding by Cdt1 is Required for Cell Proliferation
and Efficient DNA Re-Replication
Chromatin Decondensation by Cdt1 Stimulates MCM Recruitment
HBO1 and HDAC11 Regulate Cdt1-Induced Chromatin Unfolding
HBO1 and HDAC11 Influence MCM Recruitment to Cdt1Targeted HSRs
Chromatin Decondensation and MCM Recruitment by Cdt1
Involve Histone H4 Acetylation
Chromatin at Endogenous Origins of DNA Replication is More
Accessible During G1 versus S-phase

43
43
50
57
64
66
69
72
77
81
82
87

CHAPTER 4: DISCUSSION AND FUTURE DIRECTIONS
Cdt1-Induced Chromatin Decondensation Mediates MCM Loading
Chromatin Remodeling in DNA Replication
Cdt1 and Cancer
Future Directions
Cdt1-Induced Remodeling and Histone Modifications
Cdt1 and Geminin-HDAC11
Modulation of Cdt1 Function by HBO1 and HDAC11

89
89
93
94
100
101
103
106

CHAPTER 5: REFERENCES

110

ABOUT THE AUTHOR

End Page

ii

LIST OF TABLES

Table 1: Quantification of open and closed chromatin structures/HSRs

63

Table 2: Quantification of effects of HBO1, HDAC11, and Set8-HBD
on chromatin unfolding

80

Table 3: Quantification of MCM colocalization with HSRs

86

iii

LIST OF FIGURES

Figure 1:

The Pre-Replication Complex

7

Figure 2:

Origin of Replication during G1-S

9

Figure 3:

The Replication Fork

12

Figure 4:

Schematic of Cdt1

16

Figure 5:

Structure of Chromatin

21

Figure 6:

Mammalian HDAC Family Organization

27

Figure 7:

Acetylation Affects DNA Replication Initiation

35

Figure 8:

HDAC11 Chromatin Immunoprecipitation

44

Figure 9:

Cdt1 Overexpression Causes Re-Replication

47

Figure 10:

HDAC11 Suppresses Cdt1-Induced Re-Replication

48

Figure 11:

HDAC11 Overexpression Inhibits MCM Binding to Chromatin

49

Figure 12:

Verification of anti-HDAC11 Antibody

50

Figure 13:

Chromatin Binding Kinetics of HDAC11

52

Figure 14:

Graphical Representation of HDAC11 Chromatin Binding Kinetics

53

Figure 15:

Geminin Enhances the Cdt1-HDAC11 Interaction

54

Figure 16:

Geminin, HDAC11, and Cdt1 Interact in a Single Complex

56

Figure 17:

Schematic of in vivo Chromatin Remodeling System

58

iv

Figure 18:

VP16 Induces Chromatin Remodeling, but Cdc6 and LacI Do Not

59

Figure 19:

Cdt1 Induces Chromatin Remodeling

60

Figure 20:

Expression Levles of LacI-Fusion Proteins

62

Figure 21:

LacI-Cdt1 Localizes to the Nucleus

62

Figure 22:

Cdt1-Induced Chromatin Decondensation Occurs in G1-phase

65

Figure 23:

Expression Levels of LacI-Cdt1 and HA-Geminin

66

Figure 24:

Geminin Inhibits Cdt1-Induced Chromatin Unfolding

68

Figure 25:

Deletion Mutant of Cdt1 that is Defective for Chromatin Remodeling

69

Figure 26:

Cdt1 Deletion Mutant Does Not Cause Chromatin Unfolding

70

Figure 27:

Cdt1 Deletion Mutant Inhibits Cell Survival

71

Figure 28:

Cdt1 Deletion Mutant is Inhibited in Causing Re-Replication

72

Figure 29:

Cdt1-Induced Chromatin Unfolding Stimulates MCM Recruitment

73

Figure 30:

BRCA1 and VP16 Chromatin Remodeling Does Not Recruit
Endogenous MCMs

75

Figure 31:

PCNA can be Recruited to Chromatin Unfolded by Cdt1

76

Figure 32:

Quantification of Endogenous Mcm7 Recruitment

76

Figure 33:

Cdt1 Interacts with HDAC11 and HBO1 in vivo

77

Figure 34:

Expression Levels of LacI-Cdt1 with Flag-HDAC1, Flag-HDAC11,
HA-HBO1-wt, and HA-HBO1-Mutant

78

HDAC11 and HBO1-Mutant Inhibit Cdt1-Induced Chromatin
Unfolding and Subsequent Endogenous MCM Recruitment

82

Figure 36:

Expression of Flag-HDAC1 and Flag-Set8-HBD

83

Figure 37:

Blocking Histone H4 Acetylation Prevents Cdt1-Induced Chromatin
Decondensation and Endogenous MCM Recruitment

85

Figure 35:

v

Figure 38:

Chromatin at Endogenous DNA Replication Origins is More
Accessible During G1-phase than in S-phase

88

Figure 39:

Working Model

91

Figure 40:

Cdt1-Induced Remodeling Colocalizes with Methylated Histones

102

Figure 41:

Bimolecular Fluorescence Complementation between
Cdt1 and Geminin

104

Figure 42:

Geminin Mutants

105

Figure 43:

Cdt1 Deletion Mutants

107

Figure 44:

HDAC11 Specifically Blocks S-phase

108

vi

LIST OF ABBREVIATIONS

AAA+

ATPases Associated with a variety of cellular Activities

APC

Anaphase Promoting Complex

ARS

Autonomously Replicating Sequence

ATP

Adenosine Triphosphate

CDC

Cell Division Cycle

CDK

Cyclin Dependent Kinase

Cdt1

Cdc10 Dependent Transcript

DNA

Deoxyribonucleic Acid

FEN1

Flap endonuclease 1

G1-phase

Gap 1 phase

G2-phase

Gap 2 phase

GINS

Go Ich Nii and San replication complex

HAT

Histone Acetyltransferase

HDAC

Histone Deacetylase

HBO1

HAT Binding Orc1

KAT

Lysine Acetyltransferase

MCM

Mini-Chromosome Maintenance complex of proteins

vii

M-phase

Mitosis

Ori

Origin of Replication

ORC

Origin Recognition Complex

PCNA

Proliferating Cell Nuclear Antigen

PHD

Plant Homeo Domain

PIP

PCNA Interaction-Protein Motif

pol

Polymerase

preRC

Pre-Replication Complex

RFC

Replication Factor C

SAHA

suberoyl anilide bishydroxamide

Sir2

Silent Information Regulator 2

S-phase

Synthesis phase

TSA

Trichostatin A

viii

ABSTRACT

The efficiency of metazoan origins of DNA replication is known to be enhanced
by histone acetylation near origins. Although this correlates with increased MCM
recruitment, the mechanism by which such acetylation regulates MCM loading is
unknown. We show here that Cdt1 induces large-scale chromatin decondensation that is
required for MCM recruitment. This process occurs in G1, is suppressed by Geminin, and
requires HBO1 HAT activity and histone H4 modifications. HDAC11, which binds Cdt1
and replication origins during S-phase, potently inhibits Cdt1-induced chromatin
unfolding and re-replication, suppresses MCM loading, and binds Cdt1 more efficiently
in the presence of Geminin. We also demonstrate that chromatin at endogenous origins is
more accessible in G1 relative to S-phase. These results provide evidence that histone
acetylation promotes MCM loading via enhanced chromatin accessibility. This process is
regulated positively by Cdt1 and HBO1 in G1 and repressed by Geminin-HDAC11
association with Cdt1 in S-phase, and represents a novel form of replication licensing
control.
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CHAPTER 1

INTRODUCTION

Cancer
Cancer is not one specific disease, but instead is a grouping of over 100 distinct
diseases that share the fundamental characteristics of uncontrolled cellular growth and
invasiveness (Stratton et al. 2009).

Individual cancer cells escape the biological

regulatory mechanisms that control normal cellular proliferation leading to their
accumulation and dissemination (Collins et al. 1997; Frank 2007).

The spread of

cancerous cells ignores anatomical constraints, utilizing physical and chemical means to
invade surrounding tissues and metastasize to other areas of the body (Kufe et al. 2003;
Folkman 2006).

Since tumor size is directly proportionate to nutrient and oxygen

demand, angiogenesis, or neovascularization, is required to support the growth of a tumor
and its metastatic colonies (Folkman 2006).

Tumor expansion, therefore, negatively

affects the normal function of organs not only by physical disruption due to increasing
mass, but also by robbing neighboring tissues of nutrients and oxygen.
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Without

intervention, the malignant nature of these neoplasms ultimately leads to death (Kufe et
al. 2003).
Currently, cancer ranks behind only heart disease as the leading cause of mortality
both in the United States and worldwide. Nearly one in every four deaths in the United
States and more than one in every ten deaths worldwide are a direct result of invasive
tumors. As an indication of how commonplace cancer is, especially in developed nations,
the lifetime probability of developing invasive tumors for American men and women are
a daunting 44% and 37%, respectively (American Cancer Society 2009).
The high incidence of occurrence and mortality has propelled cancer to the
forefront of medical research, however the complexity and heterogeneity of these
diseases have impeded the progress towards efficacious treatments, let alone cures.
Tumors can arise from nearly every cell type and organ within the human body,
encompassing a broad-spectrum of differing cellular biologies. Although every tumor
type encapsulates different causal mechanisms that involve differing hereditary and
environmental factors, one shared characteristic underlying the transformation of a
normal cell into a tumor cell is the alteration of the genome (Stratton et al. 2009).

Genomic Instability in Cancer
The transformation of a normal cell to a tumor cell is a complex process that
involves circumventing the many safeguards inherently in place that prevent such a
negative event from occurring (Hanahan and Weinberg 2000). The genetic material of a
cell is the fundamental blueprint upon which all cellular processes and controls are based,
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therefore maintaining genomic integrity is of the utmost importance.

Improper

alterations of the genome, ranging from point mutations to chromosomal rearrangements
to gains and losses of genetic material, are known collectively as genetic instability and
are associated with the vast majority of cancers (Collins et al. 1997; Negrini et al. 2010).
In cancer cells, genomic instability commonly emerges as chromosome translocations,
gene amplifications, aneuploidy, and polyploidy.

The ultimate result of such genetic

changes result in phenotypic shifts that are favorable to growth and proliferation, while
genes encoding growth inhibitory proteins are often compromised (Lengauer et al. 1998;
Negrini et al. 2010). Genomic instability often arises out of defects in mitotic control,
DNA repair, telomere control, and DNA replication (Cahill et al. 1998; Blow and
Gillespie 2008).

The basis of this research project was to investigate one such

mechanism of control that is associated with proper assembly of the proteins involved in
DNA replication initiation.

Loss of Proliferative Control
The propelling force in cancer development is the loss of control of the underlying
mechanisms responsible for regulating cellular proliferation, also known as the cell
division cycle (Hanahan and Weinberg 2000; Evan and Vousden 2001).

As such,

regulatory vigilance of the cell division cycle at the molecular level is necessary to
prevent any minute deviations that may contribute to the transformation of a normal cell
into a neoplastic one. Extracellular growth signals and intracellular signaling cascades
act in a concerted manner to coordinate cellular growth by regulating the downstream cell
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cycle machinery. The fundamental steps of the cell cycle include copying parental DNA
(S-phase), physical division of the two daughter nuclei (Mitosis), and the periods
separating these events (Gap phases, G1 precedes S-phase and G2 precedes M). While
each of these phases is tightly regulated, the control of the G1-S transition is of particular
importance (Hartwell and Kastan 1994; Hook et al. 2007).

During this period, the

controlled assembly of the pre-Replication Complex and subsequent loading of the MCM
helicase represents an essential regulatory mechanism and proper control of this step is
crucial to ensuring the fidelity and timing of genome replication (Vaziri et al. 2003; Hook
et al. 2007). Elucidating a novel molecular mechanism by which cells regulate MCM
helicase loading, and thereby maintaining proper G1-S control, is the focus of this
research project.

Cell Cycle
To proliferate, individual cells must duplicate themselves via a series of
coordinated events known collectively as the cell cycle (Norbury and Nurse 1992). In its
essence, the cell cycle involves two basic processes: a single round of DNA replication in
which the entire genome of a cell is copied and the segregation of the replicated
chromosomes into two separate daughter cells (Collins et al. 1997).

During the cell

division cycle, DNA is replicated during the synthesis phase (S-phase) and the two copies
of each chromosome are segregated into daughter nuclei during mitosis (M-phase)
(Norbury and Nurse 1992). This is followed by the separation of the cytoplasm into two
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daughter cells, a process known as cytokinesis, which represents the final step of the cell
cycle.
S-phase and M-phase are separated temporally by what are known as gap phases,
G1 occurs between M-phase and S-phase while G2 occurs between S-phase and Mphase. During these gap phases, cells prepare for entry into either S-phase or M-phase
and gather information from throughout the cell to determine its readiness to progress to
the next phase (Pardee 1989; Johnson and Walker 1999).
Cell cycle progression is controlled by two major mechanisms.

The first

mechanism of regulation involves a cascade of phosphorylation events modulated by a
group of heterodimeric protein kinases, which drives the cell cycle forward.

The

activation of these kinases requires the physical association of a regulatory subunit, called
a cyclin, with a catalytic subunit, or cyclin-dependent kinase (CDK) (Pardee 1989;
Norbury and Nurse 1991). The substrate specificity of this activated complex derives
from the specific combination of cyclin and CDK. The cellular levels of cyclins increase
and decrease in concert with progression through the cell cycle as different cyclin-CDK
combinations are required during the different stages of the cell cycle.

The second

mechanism by which the cell cycle is regulated is known as checkpoint control (Collins
et al. 1997). Cell cycle checkpoints integrate sensory signals from within the cell to
determine if the processes of each cell cycle phase has been properly completed before
progression is permitted (Johnson and Walker 1999).

In a sense, checkpoints play a

supervisory role and sense imperfections in cell cycle processes that could lead to
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imprecise replication of DNA or flawed segregation of chromosomes potentially resulting
in unequal daughter cells or other mutations (Collins et al. 1997).
The cell cycles of normal dividing cells are tightly regulated and coordinated to
ensure faithful reproduction of the parental cells. Cancer cells must also utilize the cell
cycle machinery in order to proliferate and grow, however the regulatory mechanisms of
the cell cycle are often altered to permit the uncontrolled growth that is inherent to
neoplasia (Cahill et al. 1998; Lengauer et al. 1998).

DNA Replication
Cellular proliferation requires the faithful duplication of the parental genome
during the S-phase of the cell division cycle to ensure that each daughter cell receives an
exact copy of the mother cell’s genetic material (Dutta and Bell 1997; Bell and Dutta
2002; Masai et al. 2010). Imprecision during the replication of parental template DNA
can potentially lead to alterations in the genome that favor cancer development (Blow
and Gillespie 2008). Due to the size of the genetic template, DNA replication initiates
from thousands of separate genomic regions known as origins of replication. The DNA
that is replicated from a single origin of replication is known as a replicon (Huberman
1995). Mammalian somatic cells have large replicons that range in size from 50-kb to
500-kb and these replicons appear to replicate in clusters and in a staggered manner such
that not all active origins fire simultaneously at the onset of S-phase (Berezney et al.
2000; Ge et al. 2007; Cadoret et al. 2008). Furthermore, in a given S-phase, not all
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licensed preRCs are activated, as many are kept in reserve and only fire in response to
replicative stresses (Ge et al. 2007).

Fig. 1 The Pre-Replication Complex. The preRC is required for the initiation of
replication at a given replication origin. The preRC is comprised of an ORC hexamer,
which recruits Cdt1 and Cdc6 to the origin of replication. Cdt1 and Cdc6 are required to
load the MCM complex, which serves as the putative replicative helicase. Once the
MCM helicase is loaded, the preRC is considered to be licensed for replication.
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Initiation of DNA replication requires the stepwise assembly of a macromolecular
complex of proteins known as the pre-Replication Complex (preRC) during G1-phase of
the cell cycle (Fig. 1). The hexameric origin recognition complex (ORC) binds to the
origins of replication on DNA, forming the foundation of the preRC. ORC then recruits
Cdt1 and Cdc6, which are both required to load the hexameric Mini-Chromosome
Maintenance (MCM) helicase complex, comprised of Mcm2-7, onto DNA (Bell and
Dutta 2002; Mendez and Stillman 2003). Once loaded, the MCM complex is believed to
serve as the replicative helicase or act at the initial DNA unwinding step, or both (Chong
et al. 2000; Shechter et al. 2004). At the G1-S transition, Cdk2 and Cdc7 kinases are
activated and Mcm10, Cdc45, and DNA polymerase α/primase are recruited, initiating
bidirectional nascent strand synthesis from the origin (Fig. 2), or preRC site (Mendez and
Stillman 2003; Masai et al. 2010).
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Fig. 2 Origin of Replication during G1-S. PreRCs at origins of replication are licensed
during G1-phase. ORC recruits, Cdt1 and Cdc6, which in turn load the MCM helicase
onto chromatin. At the G1-S transition, there is an increase in cellular CDK activity, and
Cdc45, Mcm10, and DNA polymerases are recruited to the activated origins, which is
followed by bidirectional nascent strand synthesis.

9

After DNA replication initiation, two replication forks originate from a single
activated preRC and origin of replication.

As the replicative helicase unwinds and

separates the DNA substrate, RPA binds the single stranded DNA and DNA polymerase
α/primase is loaded in a process termed primosome assembly, as reviewed by Waga and
Stillman (Waga and Stillman 1998) and depicted in Figure 3. Mcm10 and Cdc45 are
necessary for the loading and retention of pol α/primase onto chromatin (Waga and
Stillman 1998; Garg and Burgers 2005).

Since DNA polymerases can only extend

existing oligonucleotides and not create them de novo, pol α/primase serves an important
role in fork progression as it is able to synthesize short RNA primers complementary to
the parental DNA strand and then extend them by approximately 20 nucleotides.
Polymerase switching then occurs and other, more processive polymerases can take over
allowing replication to continue (Garg and Burgers 2005).
DNA polymerases only synthesize DNA in the 5’ to 3’ direction, as such within
any given replication fork, one strand will be copying DNA in the same direction of
helicase unwinding, termed the leading strand (Fig. 3). The other strand, termed the
lagging strand, will copy its template in a more discontinuous fashion. Replication of the
leading strand is performed by DNA polymerase ε (Pursell et al. 2007), in a process that
is inherently faster than lagging strand synthesis. To rectify this, pol α/primase also acts
as a molecular brake for pol ε synthesis as a mechanism to coordinate leading strand and
lagging strand synthesis (Lee et al. 2006). Lagging strand replication is performed by
DNA polymerase δ and, unlike the leading strand, lagging strand synthesis requires
frequent priming by pol α/primase (Fig. 3). Thus, lagging strand synthesis has several
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discrete steps: synthesis of an RNA primer by pol α/primase, subsequent extension of this
primer by the polymerase subunit of pol α/primase, polymerase switching to allow for pol
δ to continue synthesis, excision of the RNA primers by FEN1 or RNase HI, gap filling
by pol δ, and then nick sealing by DNA Ligase I (Waga and Stillman 1998; Garg and
Burgers 2005). The latter three steps described here are known as Okazaki Fragment
Maturation and occurs 20-50 million times in every mammalian cell cycle (Garg and
Burgers 2005). PCNA, or Proliferating Cell Nuclear Antigen, plays an important role in
DNA replication elongation by acting as a processivity factor for pol δ and pol ε and is
loaded onto the DNA by RFC in an ATP-dependent manner (Tsurimoto and Stillman
1990; Waga and Stillman 1998; Garg and Burgers 2005).
The assembly of preRCs is subject to numerous limitations, especially with
respect to the timeframe when assembly can occur during the cell cycle in order to
prevent replication origins from firing more than once. Collectively, this control over
preRC assembly and MCM loading is known as “replication licensing” and is completed
once the MCMs are loaded (Blow 1993; Blow 2001; Blow and Hodgson 2002). In fact,
once the complex of MCMs has been recruited, ORC and Cdc6 (and likely Cdt1) are no
longer required for origin firing and S-phase progression.
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Fig. 3 The Replication Fork. Initiation of DNA replication involves the generation of
two replication forks moving in opposite directions from an activated origin of
replication. One such replication fork is depicted, which includes a leading strand that
synthesizes DNA in the direction of fork progression, and a lagging strand that is forced
to replicate DNA in a discontinuous fashion due to the unidirectional nature of
polymerases.
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Origin Recognition Complex
The evolutionarily conserved, hexameric Origin Recognition Complex (ORC)
binds directly to DNA and acts as the initiator of DNA replication. ORC was initially
identified in S. cerevisiae budding yeast and demonstrated binding specificity to the
autonomously replicating sequence (ARS) via the A-element (or ARS consensus
sequence), which contains the origins of replication in yeast (Bell and Stillman 1992; Loo
et al. 1995). ORC has since been found to be a vital component in all eukaryotic DNA
replication, however, unlike in yeast, a specific binding site or sequence does not seem to
exist in other organisms (Mendez and Stillman 2003; Vashee et al. 2003; Masai et al.
2010).

Instead, ORC binding to origins of replication in higher eukaryotes seems to be

more plastic and occurs in zones rather than at discrete sites (Hamlin et al. 2010). Orc2-5
stably bind to chromatin through the cell cycle, while Orc1 seems to be bound only
during G1 and becomes degraded during progression through S-phase (Ohta et al. 2003;
Tatsumi et al. 2003).
Orc1, Orc4, and Orc5 belong to the AAA+ (ATPases associated with a variety of
cellular activities) family of proteins and ATP binding stimulates ORC association with
DNA (Giordano-Coltart et al. 2005; Duncker et al. 2009).

Once ATP bound ORC has

loaded onto chromatin, it serves as an anchoring point for the remainder of the preRC
proteins to bind to.

ATP hydrolysis by ORC is necessary for reiterative loading of

preRCs onto chromatin (Bowers et al. 2004).
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Cdc6
Cdc6, or Cell Division Cycle 6, was initially identified in S. cerevisiae and is
indispensable for the loading of MCMs and preRC licensing (Bell and Dutta 2002; Cook
et al. 2002).

Cdc6 shows sequence similarity to subunits of clamp-loaders in both

eukaryotes and prokaryotes and have functionally been shown to be involved in the
loading of Mcms onto chromatin (Perkins and Diffley 1998). Similar to several of the
ORC components, Cdc6 is an ATPase that belongs to the AAA+ family of proteins
(Randell et al. 2006). Once ORC binds to the origin of replication, Cdc6 complexed to
ATP is then recruited to the site of preRC assembly along with Cdt1 to load Mcm2-7.
Cdc6 then hydrolizes ATP which results in both Cdc6 and Cdt1 dissociation from the
preRC but simultaneously stabilizes the MCM complex to chromatin (Randell et al.
2006).
Cdc6 is regulated by several mechanisms. Phosphorylation of S. cerevisiae Cdc6
(and its S. pombe fission yeast homolog Cdc18p) by CDKs results in ubiquitin-dependent
proteasomal degradation, while Cdc6 phosphorylation in X. laevis results in export from
the nucleus (Pelizon et al. 2000; Cook et al. 2002). Interestingly, phosphorylation of
human Cdc6 has the opposite effect and leads to protein stability by preventing APC/C
E3 ubiquitin ligase-dependent proteolysis (Mailand and Diffley 2005).
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Cdt1
Cdt1, CDC10 dependent transcript 1, was initially identified in S. pombe as an
essential gene product of cdc10 (Hofmann and Beach 1994). Cdt1 is highly conserved
(Bell and Dutta 2002) and homologs have since been identified in many eukaryotic
species including humans (Wohlschlegel et al. 2000), mice (Arentson et al. 2002), S.
cerevisiae (Tanaka and Diffley 2002), X. laevis (Maiorano et al. 2000), and Drosophila
(Whittaker et al. 2000).

CDT1 is an essential gene as its product is required for

chromosomal DNA replication (Maiorano et al. 2000) and mutations result in a DNA
synthesis block and errors in the S-phase checkpoint (Hofmann and Beach 1994). Cdt1 is
loaded onto chromatin prior to DNA replication in an ORC dependent manner as an
integral part of the pre-Replication Complex and is required to load the MCM2-7 protein
hexamer (Maiorano et al. 2000). In S. pombe, Cdt1 has been shown to physically interact
with the C-terminus of Cdc6 and together they act to cooperatively promote the
association of MCM proteins on chromatin (Nishitani et al. 2000). Furthermore, Cdt1 is
known to bind several DNA replication proteins directly, including PCNA (Tsurimoto
1999), Mcm4 (Cook et al. 2004), and Mcm6 (Yanagi et al. 2002) (Fig. 4).
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Fig. 4 Schematic of Cdt1. Cdt1 serves as a scaffolding protein that interacts with many
different proteins. Shown here is the C-terminal Cdt1 interaction with the MCM
helicase. The central portion of Cdt1 is responsible for the bipartite interaction with
Geminin and the interaction with HDAC11. The N-terminal region of Cdt1 contains the
PIP box for PCNA interaction and Cy motif for Cyclin/Cdk binding, both of which
mediate polyubiquitination by distinct E3 ligases. The HBO1 binding region of Cdt1 has
yet to be defined.
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Cdt1 is regulated by a small protein called Geminin (Wohlschlegel et al. 2000).
Initial reports demonstrated that Geminin acts to inhibit Cdt1 function (Wohlschlegel et
al. 2000; Yanagi et al. 2002), however, more recent evidence indicates Geminin acts also
in a positive manner to facilitate Cdt1 function (Lutzmann et al. 2006; Xouri et al. 2007).
This dual role of Cdt1 regulation by Geminin is determined by the stoichiometric ratio of
Geminin to Cdt1 within the complex where a high Geminin:Cdt1 ratio acts in an
inhibitory manner whereas a low Geminin:Cdt1 ratio facilitates Cdt1 function. The ratio
of Geminin binding to Cdt1 increases to become inhibitory after origin firing, presumably
to prevent improper MCM loading by Cdt1 (Lutzmann et al. 2006).
It is of great importance that MCM loading be limited to once during any given
cell cycle. As such, Cdt1 activity is restricted to only G1-phase of the cell cycle and this
activity is tightly regulated. In addition to Geminin, Cdt1 is also controlled by several
other mechanisms that regulate its stability (Fujita 2006).

Cyclin dependent kinases

(CDKs) represent another layer of Cdt1 control (Fujita 2006). As S-phase begins, there is
an increase in CDK activity (Bell and Dutta 2002) which results in the phosphorylation of
Cdt1 on its N-terminal cyclin-binding motif by cyclin A-dependent kinases (Liu et al.
2004; Sugimoto et al. 2004). This phosphorylation triggers Cdt1 polyubiquitination by
the SCFSkp2 E3 ubiquitin ligase complex and subsequent targeting to proteasomemediated degradation during S-phase and G2 (Li et al. 2003; Nishitani et al. 2006).
Moreover, phosphorylated Cdt1 is also impaired in its ability to bind DNA,
demonstrating multiple mechanisms by which CDKs are able to control Cdt1 function
(Sugimoto et al. 2004).

Cdt1 is further regulated by a second E3 ubiquitin ligase
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pathway, independent of SCFSkp2. During S-phase or after DNA damage, Cdt1 is targeted
for proteasomal degradation by binding to PCNA via an N-terminal motif, which results
in ubiquitination by the Cul4/Ddb1 E3 ligase (Hu et al. 2004; Hu and Xiong 2006;
Nishitani et al. 2006; Senga et al. 2006) (Fig. 4).
The multiple levels of control over Cdt1 are important factors in the overall
regulation of replication licensing. Controlling MCM chromatin loading is of critical
importance to the cell in that it allows one and only one round of DNA replication to
occur, and prevents the inappropriate reloading of MCMs and subsequent re-replication
(i.e., relicensing) that can cause genomic instability. Improper overexpression of Cdt1
(Vaziri et al. 2003) or Geminin depletion (Melixetian et al. 2004; Zhu et al. 2004) can
lead to re-replication, demonstrating the importance of Cdt1 regulation. In fact, Cdt1 can
act as an oncogene and is found to be overexpressed in several human cancers including
some carcinomas, melanomas, leukemias, and lymphomas (Arentson et al. 2002; Seo et
al. 2005; Liontos et al. 2007). Cdt1 overexpression alone in NIH3T3 cells can cause
tumor formation in nude mice (Arentson et al. 2002).
Whereas Cdc6 has been proposed to function as an MCM clamp loader (Perkins
and Diffley 1998), the mechanisms by which Cdt1 promotes MCM loading are less clear.
Unlike other components of the preRC, Cdt1 does not possess any known enzymatic
motifs and its actual biochemical role in the loading of the MCM complex is unknown.
Instead, Cdt1 seems to act as a scaffolding protein and its interactions with other proteins
determine its physiologic roles (Sugimoto et al. 2008). The work contained within this
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dissertation describes a novel mechanism of Cdt1 function that utilizes cell cycle time
dependent interactions with specific enzymes to mediate the loading of MCMs.

MCM Complex
The MCM2-7 (mini-chromosome maintenance) family of proteins were grouped
together based on sequence similarity and initially identified in genetic screens for
mutations defective for plasmid maintenance or cell cycle progression (Dutta and Bell
1997). MCM deletion results in loss of cell viability in S. cerevisiae and the loading of
the Mcm2-7 complex onto chromatin represents the final step of preRC assembly (Hua
and Newport 1998; Mendez and Stillman 2000). The heterohexameric Mcm2-7 complex
is thought to form a ring structure once loaded, with the DNA passing through the long,
central channel (Remus et al. 2009).
The MCM complex is largely believed to act as the replicative helicase, either
alone or as a part of a larger complex with GINS and Cdc45, unwinding the DNA double
helix allowing for DNA polymerase to gain access to its substrate and to accommodate
replication fork progression (Chong et al. 2000; Sato et al. 2000; Shechter et al. 2000;
You et al. 2002; Moyer et al. 2006) (Fig. 3). All members of this heterohexamer are
ATPases and members of the AAA+ family (Ying and Gautier 2005).

As discussed

above, ORC, Cdc6, and Cdt1 are temporally regulated to prevent improper loading of
MCMs. The MCM complex itself is also regulated in a cell cycle-dependent manner.
MCMs can only associate with DNA in the absence of CDK activity, since CDK activity
is required at the onset of S-phase, MCMs are prevented from re-associating with
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chromatin after replication has begun (Hua et al. 1997). The purpose of this research
project was to elucidate a novel form of MCM loading control that involves the
modulation of chromatin structure as a mechanism of replication licensing.

Pre-Replication Complex Quantification
Little is known about mammalian preRC stoichiometry, the number of preRCs on
chromosomes, and how this relates to replicon size and usage. Our laboratory has found
that, on average, each 100-kb of the mammalian genome contains a preRC composed of
one ORC hexamer, 4-5 MCM hexamers, 2 Cdc6 proteins, and 0.35 Cdc45 proteins.
Thus, based on ORC availability, mammalian cells, whose diploid genomes are
approximately 7x109 bp, contain approximately 70,000 preRCs of this average total
stoichiometry. However, except for ORC, the chromatin-bound complement of preRC
subunits is even lower.
Cdc45 is highly stable, and the same limited number of stable Cdc45 molecules
are present from the beginning of S-phase to its completion. Microinjection of excess
purified Cdc45 into S-phase nuclei activates additional replicons by three-fold, indicating
that Cdc45 functions to activate dormant preRCs and is rate-limiting for replicon usage
and activation. This low density of preRCs, each containing only a few MCMs that
compete for limiting amounts of Cdc45, provides a molecular explanation why somatic
replicons are large in average size. The stable, continuous, and rate-limiting nature of
Cdc45 suggests that Cdc45 contributes to the staggering of replicon usage, and that
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replicon activation requires reutilization of existing Cdc45 during S-phase (Wong et al.
manuscript submitted 2010).

Chromatin

Fig. 5 Structure of Chromatin. Double stranded DNA does not and cannot exist as a
lone molecule within the cell, instead DNA is packaged within the nucleus by winding
around a core histone octamer to form a nucleosome. The nucleosomes are organized
into higher-order chromatin structures, including a 30nm fiber “solenoid”.
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DNA does not exist within the nucleus as a naked molecule.

Instead, it is

wrapped tightly around a positively charged histone core octamer that is comprised of
two histone H2A/H2B dimers and a histone H3/H4 tetramer (Wolffe and Hayes 1999).
This DNA-histone structure is known as a nucleosome, and represents the most basic unit
of chromatin (de Ruijter et al. 2003) and are formed during DNA replication (Saha et al.
2006).

Nucleosomes are connected with linker DNA of variable lengths, forming a

beads-on-a-string structure, which organize into a more compact 30 nm fiber (Wu et al.
2007).

30 nm fiber structures are further condensed into higher-order chromatin

structures within the nucleus.
This packaging of DNA creates a physical barrier for processes that require DNA
as a substrate, which leads to a fundamental accessibility issue for proteins involved in
transcription, DNA repair, and DNA replication (Demeret et al. 2001). Areas of the
genome, known as euchromatin, are less tightly compacted, therefore these regions are
more actively transcribed and replicate earlier in S-phase compared to condensed
chromatin regions known as heterochromatin. Thus, manipulation of chromatin structure
represents an important level of spatio-temporal control for transcription and DNA
replication (Demeret et al. 2001).
Two major classes of proteins are able to affect the condensation state of
chromatin: ATP-dependent chromatin remodelers and histone modifying enzymes
(Sengupta and Seto 2004).

ATP-dependent remodelers utilize the energy of ATP to

mediate chromatin remodeling by physically altering the position of nucleosomes on the
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genome (Vignali et al. 2000). ATP-dependent remodelers are organized into five major
families: SWI/SNF, ISWI, CHD, SWR1, and INO80 (Saha et al. 2006; Hayashi and
Masukata 2010). Post-translational covalent modification of core histones, to both tail
and globular domain residues, and linker histone H1 are also an important mechanism to
facilitate chromatin remodeling. A diverse array of modifications, including acetylation,
methylation, phosphorylation, ribosylation, and ubiquitination, can bring about changes
in chromatin fluidity either themselves by altering the histone-DNA interaction or by
creating a pattern of modifications that are recognized by downstream, effector proteins
(Strahl and Allis 2000). The recognition of one or more sequential modifications by
effector proteins or protein complexes is known as the “histone code”.

Histone Acetyltransferases
An acetylation reaction describes the process of adding an acetyl group (-COCH3)
to a molecule, which is catalyzed in biological systems by histone acetyltransferases, or
HATs.

HATs, are divided into five large families: Gcn5-related acetyltransferases,

MYST family HATs, p300/CBP HATs, general transcription factor HATs, and the
hormone receptor-related HATs (Carrozza et al. 2003b). HATs often function as part of
large, multi-subunit complexes that transfer acetyl groups onto lysine residues of histone
tails and, though less frequently, histone globular domains.
Genomic regions containing acetylated histones are generally associated with
increased transcriptional activity.

The widely accepted consequence of histone

acetylation is the partial neutralization of the positive charge on histones, which in turn,
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diminishes its association with negatively charged DNA, thus loosening the chromatin
structure (Sengupta and Seto 2004).

Common acetylated residues associated with

transcriptionally active, open chromatin include acetylated histone H4K5, 8, 12, and 16,
acetylated histone H3K9, 14, 18, and 23, acetylated histone H2AK5 and 9, and acetylated
histone H2BK5, 12, 15, and 20 (Strahl and Allis 2000; Rice and Allis 2001). Though this
is not mutually exclusive of a role in the histone code mode of function for acetylation
where acetylated lysine residues are recognized by downstream effectors, such as
bromodomain containing proteins (Yang and Seto 2007).
In addition to effects on histones and chromatin structure, acetylation also
represents an important post-translational modification for non-histone proteins (Glozak
et al. 2005).

Reversible acetylation of non-histone proteins alters the electrostatic

properties of the protein and can subsequently influence protein stability, protein-protein
interactions, protein localization, and DNA binding (Glozak et al. 2005; Minucci and
Pelicci 2006). Therefore, reversible acetylation plays a role in a diverse array of cellular
processes, including affecting proteins involved in gene expression, replication, DNA
repair, translation, cell signaling, apoptosis, the cytoskeleton, and metabolism (Yang and
Seto 2007).

Recently, global, high-resolution mass spectrometry analysis has

demonstrated that the regulatory scope of the acetylome is comparable to the diverse
spectra of protein phosphorylation (Choudhary et al. 2009).
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HBO1
HBO1 (histone acetyltransferase binding to ORC, also known as KAT7 or
MYST2) is a MYST family HAT that was first identified by screening a HeLa cDNA
library in a yeast two-hybrid system using human ORC1 as bait (Iizuka and Stillman
1999).

The HBO1 HAT complex contains JADE1/2/3, Eaf6, and tumor suppressor

proteins ING4/5. JADE1 positively influences the acetyltransferase activity of HBO1
(Foy et al. 2008) and the PHD finger domains contained within the ING4/5 and JADE
subunits influence HBO1 HAT complex targeting through preferential associations with
methylated histone H3 (Saksouk et al. 2009).
HBO1 is primarily responsible for the acetylation of lysines 5, 8, and 12 of
histone H4 (Doyon et al. 2006) and plays a role in preRC licensing (Iizuka et al. 2006).
Furthermore, HBO1 binds to mammalian origins through a physical interaction with Cdt1
and acetylates histone H4 tails at origin regions during G1-phase, which is required for
MCM helicase recruitment (Miotto and Struhl 2008; Miotto and Struhl 2010).
Acetylation by HBO1 is also inhibited by Geminin in a mechanism that depends on
binding to the HBO1-Cdt1 complex (Miotto and Struhl 2010). p53 binds to HBO1 and
inhibits its acetyltransferase activity and the subsequent MCM loading in response to
certain cytotoxic shocks (Iizuka et al. 2008). Interestingly, HBO1 has been found to be
overexpressed in cancer cell lines and cancer tissues, which corresponds with its
necessary role in preRC licensing (Iizuka et al. 2009).

The work contained in this

research project describes a mechanism by which Cdt1 acts to decondense chromatin to
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facilitate MCM loading in a process that requires histone H4 acetylation and is inhibited
by coexpression of a catalytically-dead mutant of HBO1.

Histone Deacetylases
Histone deacetylases (HDACs) catalyze the opposite reaction to HATs, namely
the removal of the acetyl moiety from ε-amino groups of lysine residues in both histone
and non-histone proteins. By opposing the reaction of HATs, HDACs inherently play a
fundamental role in the many biological processes that acetylation affects as described
previously. Since histone acetylation neutralizes that positive charge on the histone and
decreases its affinity with DNA, deacetylation has the converse effect and restores the
positive charge on the histone, which results in a tighter, more compact chromatin
structure (de Ruijter et al. 2003; Sengupta and Seto 2004).

As shown in Figure 6,

mammalian HDACs are organized into two major families and four subclasses based on
their sequence homology to yeast counterparts and cofactor dependencies (Yang and Seto
2007).
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Fig. 6 Mammalian HDAC Family Organization.
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Class I HDACs
Mammalian class I HDACs show sequence homology to yeast RPD3, contain an
N-terminal deacetylase domain and a C-terminal tail, and include HDAC1, HDAC2,
HDAC3, and HDAC8 (Yang and Seto 2008). Class I HDACs appear to be expressed in
most cells and are almost exclusively found in the nucleus (de Ruijter et al. 2003). The
conserved deacetylase core is shared by classical HDACs and encompasses
approximately 390 amino acids. Within this conserved deacetylase domain exists a tubelike pocket that houses the zinc ion cofactor (Finnin et al. 1999). The Zn2+ ion serves as a
part of a charge-relay system that also utilizes adjacent histidine residues and two aspartic
residues to catalyze the removal of acetyl groups (Finnin et al. 1999; de Ruijter et al.
2003).
The classical HDACs are all inhibited by trichostatin A (TSA) and suberoyl
anilide bishydroxamide (SAHA) that act by inserting into the deacetylase pocket and
forming a coordinate interaction with the Zn2+ ion and active site residues to impede the
charge-relay system (Finnin et al. 1999). All class I members, with the exception of
HDAC8, function within larger nuclear complexes that serve to repress transcription and
modulate the epigenetic landscape. For example, HDAC1 and HDAC2 are both found in
Sin3, Mi-2/NuRD, and CoREST complexes and HDAC3 is a part of the N-CoR/SMRT
complex, all of which act to silence transcription (Yang and Seto 2008).
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Class II HDACs
Class II HDACs show sequence homology to yeast Hda1 and depend on Zn2+ ion
as a cofactor for their deacetylase function. Like class I HDACs, class II HDACs are
inhibited by TSA and SAHA. While class I HDACs are widely expressed in mammalian
cells, class II HDACs appear to be more restricted in terms of expression in different cell
types, suggesting they may play a role in differentiation and development (de Ruijter et
al. 2003). The class IIa members, comprised of HDAC4, HDAC5, HDAC7, and HDAC9
all share a conserved, long N-terminal extension in addition to their similar deacetylase
domains (Yang and Seto 2008).
Contained on these class IIa N-terminal extensions are binding sites for 14-3-3
and myocyte enhancer factor 2 (MEF2) (de Ruijter et al. 2003). The binding of these
proteins to the class IIa HDACs affects their subcellular localization with MEF2
promoting nuclear localization whereas 14-3-3 promotes cytoplasmic retention.

This

dynamic nuclear/cytoplasmic transport of class IIa HDACs makes them unique signal
transducers as they are actively shuttled in response to multiple cellular signals. HDAC6,
a class IIb HDAC, is unique in that it is predominantly cytoplasmic and contains two
active deacetylase domains. Given its subcellular localization, it serves as an important
cytoplasmic, non-histone protein deacetylase and plays a role in a variety of cellular
functions including cellular motility, cellular adhesion, activation of certain kinases, and
regulating some immunologic functions (Yang and Seto 2008).
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Class III HDACs
Class III HDACs, termed Sirtuins, represent a distinct family from the classical
HDACs and are homologous to the S. cerevisiae SIR2 (Silent Information Regulator 2).
Seven human sirtuins, numbered Sirt1-7, have been identified to date and not all possess
the ability to act as protein deacetylases, instead some act as mono-ADP
ribosyltransferases. Sirtuins differ from classical HDACs in terms of their enzymatic
mechanism, subcellular localization, structure, sequence, and function (Michan and
Sinclair 2007). Instead of utilizing Zn2+ ion as a cofactor, Sirtuins employ NAD+ as a cosubstrate for the enzymatic removal of acetyl groups. Sirt1, Sirt2, Sirt3, Sirt5, and Sirt6
display deacetylase activity, while Sirt4 possesses only the ability to act as a
ribosyltransferase. Interestingly, Sirt2, Sirt3, and Sirt6 have the ability to catalyze both
deacetylase reactions and ribosyltransferase reactions (Frye 1999; Liszt et al. 2005).
Since their mechanism of action is so different than the classical HDACs, it is no
surprise that TSA and SAHA are incapable of acting as inhibitors to the class III HDACs,
instead sirtuins are inhibited by nicotinamide, a byproduct of their deacetylation reaction
(Landry et al. 2000). Sirt1, Sirt6, and Sirt7 reside predominantly in the nucleus, while the
others are cytoplasmic proteins.
mitochondria.

Interestingly, Sirt3, Sirt4, and Sirt5 reside in the

Sirtuins represent a relatively new area of HDAC research and many

strides are being made to elucidate their impact on biological functions (Michan and
Sinclair 2007).
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Class IV HDAC: HDAC11
Identified in 2002, HDAC11 is the lone member of the class IV HDAC grouping.
HDAC11 possesses similarity to class I HDACs and, to a lesser degree, class II HDACs,
however its sequence similarity was too low to designate it as a member of either class
(Gao et al. 2002; de Ruijter et al. 2003). HDAC11 does exhibit the qualities of a classical
HDAC in that it requires Zn2+ ion as a cofactor for its deacetylase activity and is inhibited
by TSA.

It is primarily localized to the nucleus, however it has been shown to co-

immunoprecipitate with the cytosolic HDAC6 protein (Gao et al. 2002). HDAC11 is
conserved from C. elegans, Drosophila, bacteria, plants, to humans (Yang and Seto
2008).

This high level of evolutionary conservation suggests HDAC11 possesses an

important function in a diverse range of organisms.
Expression of HDAC11 in Antigen Presenting Cells (APCs) functions to inhibit
IL-10 expression and induced inflammatory APCs to prime naive T cells and restore the
responsiveness of tolerant T helper cells (Villagra et al. 2009).

HDAC11 is highly

expressed in murine brain cells (Liu et al. 2008) and seems to play a role in the regulation
of oligodendrocyte-specific protein gene expression and oligodendrocyte development
(Liu et al. 2009). Recently, an S-phase, direct interaction between HDAC11 and Cdt1 has
been identified (Glozak and Seto 2009). Cdt1 was also found to be acetylated at its Nterminus by the HATs PCAF and p300, and overexpression of HDAC11 correlated with
reduction in acetylated Cdt1.

This reversible acetylation protects Cdt1 from

ubiquitination and resulting proteasomal degradation, thus representing a potential
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mechanism to regulate Cdt1 stability (Glozak and Seto 2009).

Due to its recent

discovery, further biological roles of HDAC11 have yet to be fully elucidated,
particularly with respect to regulation of DNA replication. The research contained within
this dissertation describes a novel role for HDAC11, in which it plays a role in regulating
MCM loading by Cdt1 by manipulating chromatin structure.

Chromatin Remodeling in DNA Replication
As described above, the condensation of the DNA substrate into nucleosomes and
higher-order chromatin structures poses a fundamental problem for proteins and enzymes
that require access to the DNA in order to function and represents an important regulatory
component. Although this issue of chromatin accessibility is a highly-studied topic in the
field of transcriptional control (Wolffe and Hayes 1999; Hassan et al. 2001; Carrozza et
al. 2003a), very little is known about how chromatin influences DNA replication, in terms
of both initiation and elongation. Just as in transcription, it is easily predicted that access
to the DNA within the context of chromatin by the replication machinery represents an
important regulatory step. In addition to creating access to DNA for preRC formation
prior to S-phase, specific DNA-histone interactions need to be disrupted and recreated
during the cell cycle to maintain faithful duplication of the genome and its chromatin
structures (Falbo and Shen 2006).
Experiments in yeast, where ORC binding is more specific than higher
eukaryotes, have demonstrated that nucleosomal positioning can affect ORC binding and
preRC assembly (Falbo and Shen 2006; Hayashi and Masukata 2010). When ARS DNA
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is repositioned from an accessible area to one masked by a nucleosomal core particle,
DNA replication is inhibited (Simpson 1990). In support of this, replication origins, i.e.
poly(dA-dT) regions, and ORC localization in S. cerevisiae yeast maps to nucleosomefree regions using high-throughput sequencing (Eaton et al. 2010).

While similar

genome-wide nucleosome positioning mapping in S. pombe resulted in differing
nucleosome-depleted region patterns, nucleosome depletion was also detected over high
efficiency origins la(Lantermann et al. 2010).

Interestingly, others have shown that

nucleosomal positioning adjacent to ARS1 can enhance replication initiation, suggesting
ORC binding and preRC formation efficiency may be dependent on chromatin context
(Lipford and Bell 2001). Together, these data suggest nucleosomal positioning plays an
important role in determining origin efficiency in eukaryotic cells.
It has previously been shown that, during replication fork elongation, Cdc45
recruits Cdk2 to forks and leads to phosphorylation of the linker histone H1 (Alexandrow
and Hamlin 2005).

This histone H1 phosphorylation causes higher-order chromatin

structures to be opened and for fork progression to occur. Significantly, such findings
produced a novel explanation as to how the replication machinery is able to progress
through higher-order chromatin, particularly heterochromatic areas, which contain
highly-condensed and largely inaccessible DNA.
With respect to chromatin remodeling at sites of replication initiation, initial
studies have shown acetylation to be an important post-translational modification in
determining origin fitness. In yeast, deletion of the HDAC Rpd3 leads to overall genome
replication initiating earlier in S-phase, as well as causing several normally late-firing
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origins to fire earlier (Vogelauer et al. 2000; Vogelauer et al. 2002). Conversely, targeting
the Gcn5 HAT to a late-firing origin causes it to fire earlier than normally observed in
wild type cells (Vogelauer et al. 2000). Very similar results were obtained with an origin
studied in Drosophila as Rpd3 deletion resulted in increased genomic replication
(Aggarwal and Calvi 2004). Targeting the Drosophila homolog of Rpd3 to a specific
origin of the chorion locus reduced replicative activity, whereas targeting the Chameau
acetyltransferase resulted in increased origin activity (Aggarwal and Calvi 2004).
Furthermore, in mammalian cells, firing of the β-globin origin is influenced by local
acetylation state (Goren et al. 2008). Targeting of HATs to this region brings about a shift
to earlier replication, that depends on the acetyltransferase activity as a CBP catalytically
dead mutant did not result in the same level of S-phase time reduction.

In contrast,

targeting an HDAC to β-globin in erythroblasts, which normally replicate this region
early in S-phase, results in a shift to late replication (Goren et al. 2008). Consistent with
this, HBO1 deletion inhibits preRC licensing and DNA replication as discussed above
(Iizuka et al. 2006). Together, these date describe a situation in which histone acetylation
plays an important role in DNA replication initiation, however none full demonstrate a
direct link between this acetylation event, chromatin remodeling, and DNA replication.
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Fig. 7 Acetylation Affects DNA Replication Initiation. In yeast, global deletion of the
HDAC Rpd3 results in earlier replication firing, while targeting the Gcn5 HAT results in
earlier origin firing. In flies, global disruption of Rpd3 resulted in increased replication.
Targeting Rpd3 to a specific origin reduced replicative activity whereas tethering the
Chameau acetyltransferase resulted in increased origin activity. In mammalian cells,
targeting a HAT stimulates earlier origin firing while targeting an HDAC causes delayed
origin activity. Global deletion of the HAT HBO1 also disrupts DNA replication and
preRC licensing.
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CHAPTER 2

MATERIALS AND METHODS

Cell Culture
CHO, A03_1, and HeLa cell lines were maintained in Minimum Essential
Medium, MEM, (Cellgro) supplemented with 10% Fetal Clone II (HyClone) and 0.1%
Gentamicin (Gibco).

HaCaT and 293T cell lines were maintained in Dulbecco’s

Minimum Essential Medium, DMEM, (Cellgro) supplemented with 10% FBS (HyClone)
and 0.1% Gentamicin (Gibco). A03_1 cell medium also contained 0.3 µM methotrexate.
Cells were synchronized by isoleucine deprivation (CHO) or serum deprivation (HaCaT)
as described (Alexandrow and Hamlin 2005; Mukherjee et al. 2010). Replicating DNA
was labeled with 15 µM BrdU for 30 minutes at 37oC.

Transfections
Transfections were performed for 24 hours with FuGene-6 (Roche) or by
treatment with polyethylenimine, PEI, as described (Reed et al. 2006). Briefly, freezethawed PEI reagent was diluted in 150 mM NaCl before plasmid DNA addition.
Mixtures were vortexed and incubated at room temperature for 30 minutes before adding
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directly to cell media. Initial transfection efficiencies were determined by transfection of
Zsgreen plasmid for 24 hours and subsequent analysis by fluorescent microscopy.
Adenoviral infection assays were performed as described (Vaziri et al. 2003). Colony
forming assays used pTK-Hygro co-transfected and hygromycin selection (400 µg/ml).

Antibodies
Anti-LacI (Stratagene or Upstate); anti-BrdU (Roche); anti-H1P (provided by C.
Mizzen, University of Illinois); anti-HBO1 (provided by M. Smith, University of
Virginia); anti-Geminin, anti-Myc (S. Cruz Biotech); anti-HDAC11, anti-Flag, anti-actin
(Sigma); anti-PCNA, anti-tubulin (Calbiochem); anti-HA (Covance); anti-Cdt1 (provided
by H. Nishitani, Kyushu University, Japan); anti-Mcm2, anti-Mcm4, and anti-Mcm7
were generated by Covance or Aves Labs.

Anti-mouse, anti-rabbit, and anti-chicken

HRP-conjugated secondary antibodies (Jackson) were used. Anti-mouse, anti-rabbit, and
anti-chicken Texas Red or FITC-conjugated secondaries (Jackson) for
immunofluorescence were used.

Plasmids and cDNAs
HsCdt1, HsGeminin, and pEBG-GST were provided by A. Dutta (University of
Virginia).

HsCdt1, CgCdc45, CgCdc6, BRCA1(6c-w mutant), HsHDAC1, and

HsHDAC11 were expressed using pRcLac (Alexandrow and Hamlin 2005). No NLS
sequence was added to any LacI construct. LacI-VP16 was provided by A. Belmont
(University of Illinois).

HBO1-wt and HBO1-G485A were provided by M. Smith

37

(University of Virginia). Geminin, Cdc6, HBO1-wt, and HBO1-G485A were expressed
from pcDNA3-HA, and HBO1-wt, HDAC1, and HDAC11 were expressed from
pcDNA3-Flag. Cdt1 was expressed using pcDNA3-6xMyc. Set8-HBD was generated
by proofreading PCR and expressed using pcDNA3-HA-NLS.

Protein Chemistry
Immunoprecipitations (IP) were performed in TNN (50 mM Tris, pH7.4, 250 mM
NaCl, 0.1% Igepal CA-630, and phosphatase and protease inhibitors).

Immune

complexes were washed with lysis buffer 3X. For immunoblots, equal numbers of cells
were lysed and boiled in loading dye (for total lysates [TCE]) or were separated into
detergent-resistant (chromatin) or detergent-soluble fractions as described (Mendez and
Stillman 2000; Alexandrow and Hamlin 2005). PreRC subunits present in the chromatin
fraction are sensitive to nuclease digestion (Mendez and Stillman 2000). TCE, soluble,
and/or chromatin samples representing equivalent cell numbers were analyzed by
standard immunoblotting and ECL. Briefly, samples were loaded onto 10% SDS-PAGE
gels and then transferred to Immobilon PVDF Transfer Membranes (Millipore) with
subsequent probing with appropriate antibodies.

For gel filtration, Myc-Cdt1, Flag-

HDAC11 and HA-geminin were co-transfected into 293T cells using Lipofectamine
2000. Cells were collected and lysed with sonication in PBS lysis buffer containing 0.2%
NP-40. Lysates were purified over an anti-Flag column (Sigma). Flag-HDAC11 and copurifying proteins were eluted using a Flag peptide (Sigma). Eluates were subjected to a
size exclusion column (Superdex 200 HR 10/30 column, GE) using FPLC, and 0.3 mL

38

fractions were collected and analyzed by immunoblotting.

Immunofluorescence
Cells were analyzed by IF and BrdU incorporation as described (Alexandrow and
Hamlin 2005; Winter et al. 2009). Briefly, cells grown on square microscope coverslips
were rinsed 1x with RT PBS-pH7.4 and then fixed with either 2% formaldehyde (Fisher)
for 15 minutes at room temperature or with 100% methanol (Fisher) for 5 minutes at
-20oC. Cells were then washed 2x with PBS-7.4 and then permeabilized with PBS-7.4
containing 1% Normal Donkey Serum (NDS, from Jackson) and 0.2% Triton X-100
(Promega), then washed 2x with PBS containing 1% NDS.

If replicating DNA was

labelled with BrdU, DNA was then denatured with 1.5N HCl (in H2O) for 30 minutes at
RT and washed with PBS-7.4. Cells were then incubated for 1 hour at RT in a humidified
chamber with the appropriate primary antibody dilution in PBS-7.4 with 1% NDS. Cells
were then washed 2x at RT with PBS-7.4 with 1% NDS. Cells were then incubated again
for 1 hour at RT in a humidified chamber with the appropriate fluorescent dye-conjugated
secondary antibody diluted in PBS-7.4 with 1%NDS. Cells were then washed 2x at RT
in PBS then stained for 5 minutes with 0.5 µg/mL DAPI (4',6-diamidino-2-phenylindole)
and washed. Coverslips were then mounted on slides using 50 µL of Prolong Antifade
reagent (Molecular Probes). Photographs of cells were obtained with a Zeiss Automated
Upright Fluorescence Microscope in the Moffitt Cancer Center Analytic Microscopy
Core, and images were merged using Adobe Photoshop.
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Flow Cytometry
For flow analysis of DNA re-replication, cells were trypsinized, washed with
PBS-7.4, and then initially fixed with 1% formaldehyde (Fisher). Cells were then washed
in PBS-7.4 and then fixed and stored in 70% ethanol (Fisher) at -20oC overnight. After
centrifugation to remove ethanol, cells were washed in PBS-7.4 and then resuspended in
PBS-7.4 containing 30 µg/mL propidium iodide (PI), 0.1% Triton X-100, and 200 µg/mL
RNase A. Sample data were collected at the Moffitt Cancer Center Flow Cytometry Core
Facility with a FACScan bench-top analyzer and data was analyzed using ModFit LT
(VSH) and FlowJo software for percentage of cells containing greater than 4N DNA
content.

ChIP Assays and qPCR
Synchronized HaCaT cells were fixed with 1% formaldehyde for 10 min at room
temperature. Crosslinked chromatin was sonicated in 10 mM Tris-HCl (pH8), 1 mM
EDTA, 0.5 mM EGTA, 1% SDS (plus phosphatase and protease inhibitors) to an average
length of ~500 bp. Samples were adjusted to 5 mM Tris-HCl (pH8), 30 mM NaCl, 0.2%
Triton X-100, 0.2% SDS, 0.8% BSA, 0.4 mM EDTA, 0.1 mM EGTA, and chromatin
from 5 x 106 cells was used for IP with anti-HDAC11 or control IgG (4oC overnight).
Immune complexes were precipitated with anti-rabbit agarose, washed, and eluted in 10
mM Tris-HCl (pH8), 1 mM EDTA, 1% SDS at 65oC. Crosslinks were reversed at 65oC
overnight, and samples were treated with Proteinase K for 3 hr at 50oC. Resulting DNA
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was purified using phenol/chloroform extractions, and subjected to quantitative PCR
(qPCR) in triplicate using a BioRad MyIQ detection system with TaqMan primers and
FAM probes against previously described origin sequences (Ladenburger et al. 2002;
Sibani et al. 2005). Primers used were as follows:
Lamin B2 origin probe: 5‘-TTAGACATCCGCTTCATTAGGGCAGAGG-3’
Lamin B2 origin forward: 5’-GCTACACTAGCCAGTGACCTT-3’
Lamin B2 origin reverse: 5’-GTTCTGCCTCTGAGTTTATTCCTG-3’
Lamin B2 exon probe: 5’-CTGAACTGGGATCTGACACCCACCA-3’
Lamin B2 exon forward: 5’-AGAAGAGACCAGGGTTCACAGA-3’
Lamin B2 exon reverse: 5’-GTGTTAACAGTCAGGCGCAT-3’
MCM4 origin probe: 5’-ACCCAAACTACCTCCGCAGGTCAGACGT-3’
MCM4 origin forward: 5’-TGGCCCGAATCAACATGGAA-3’
MCM4 origin reverse: 5’-AGCCAAGTCCAACACCAAGT-3’
MCM4 exon 9 probe: 5’-CCCACCGCAGCTCCCTACATTCCTT-3’
MCM4 exon 9 forward: 5’-TCCTCGACCCTGCTTTATGA-3’
MCM4 exon 9 reverse: 5’-TGCTGCAACAGACAGCAACA-3’
As previously described (Birch et al. 2009), the enrichment of specific genomic DNA
sequences was determined based on the threshold cycle (Ct) for each PCR product and
analyzed according to the formula 2-Δ[Ct(IP)-Ct(input)]-2-Δ[Ct(control

IgG)-Ct(input)].

Using this

method, DNA relative to input and immunoprecipitated by anti-HDAC11 was normalized
to DNA immunoprecipitated by control IgG. P values were obtained using the Student's
two-tailed T-test.
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DNase I Accessibility Assays
Chromatin was isolated in a buffer containing 10 mM Tris-HCl (pH7.5), 5 mM
MgCl2, 1 mM CaCl2, 10 mM KCl, 300 mM sucrose and 0.1% Triton X-100 for 5 min on
ice, then washed and resuspended with the same buffer lacking detergent. One third of
the chromatin from a 10 cm plate of cells was digested with DNase I (Promega) at 3
Units/100 µl for 10 min at RT. Another third was treated identically, but without DNase I
(used for nomalization; untreated control). Reactions were stopped by addition of 10 mM
EDTA/2 mM EGTA and incubated at 65oC for 10 min. DNA was lightly sonicated, then
purified and analyzed using TaqMan-based qPCR as described for ChIP assays.
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CHAPTER 3

RESULTS

HDAC11 Associates with Replication Origins, Inhibits Cdt1-Induced
Re-Replication, and Suppresses MCM Loading
HBO1 interacts with Cdt1 at origins specifically during G1 and acetylates H4
tails, which is required for MCM loading (Miotto and Struhl 2008; Miotto and Struhl
2010).

The acetylation diminishes during S-phase, a time when MCM loading is

normally prevented (Miotto and Struhl 2010), suggesting that a histone deacetylase may
be involved in negatively regulating MCM loading.

HDAC11 interacts directly with

Cdt1 in S-phase (Glozak and Seto 2009) and can deacetylate H4 tails (Gao et al. 2002;
Villagra et al. 2009), but is poorly understood in terms of its physiological function in
cells. As such, we asked if HDAC11 could bind to origins in S-phase and negatively
influence MCM loading and DNA replication. Chromatin immunoprecipitation (ChIP)
analyses performed on two origins previously studied for HBO1 interactions (Miotto and
Struhl 2008) demonstrated that HDAC11 becomes bound to MCM4 and Lamin B2
origins in S-phase but not in G1, whereas nearby chromosomal regions show a small, but
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non-significant increase in HDAC11 (Fig. 8). Therefore, HDAC11 interacts with Cdt1
and associates with chromosomal origins with the opposite kinetics of HBO1 (i.e., during
S-phase), providing an explanation for why, in addition to reduced HBO1 activity, the H4
acetylation diminishes during S-phase (Miotto and Struhl 2010).

Fig. 8 HDAC11 Chromatin Immunoprecipitation. Synchronized HaCaT cells (as
verified by BrdU incorporation and subsequent analysis by fluorescent microscopy,
quantified results graphically shown in top panel) were subjected to anti-HDAC11 ChIP
and qPCR analysis at the indicated time points to determine interactions to origin
sequences (MCM4 Ori and Lamin Ori) and non-origin sequences (MCM4 exon 9 and
Lamin exon).
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Co-expression of HBO1 has been shown to enhance Cdt1-induced re-replication
(Miotto and Struhl 2008). Given that HDAC11 associates with Cdt1 and origins in Sphase and our observation that HDAC11 overexpression in CHO by transient transfection
suppresses BrdU incorporation compared to non-transfected cells (data not shown), we
reasoned that HDAC11 might act in an opposite manner to HBO1 and suppress Cdt1induced re-replication. Adenoviruses were used to overexpress Cdt1 (Vaziri et al. 2003)
at three different levels, which produced a dose-dependent increase in the percentage of
cells with >4N DNA content as determined by propidium iodide staining and subsequent
FACS analysis (Fig. 9). Overexpression of HDAC11 alone did not result in changes to
the distribution of cells within the cell cycle (data not shown), but co-expression of
HDAC11 with Cdt1 caused a significant reduction in the number of re-replicating cells
(Fig. 10, top panels).

Interestingly, expressing more Cdt1 diminishes the inhibitory

effects of HDAC11 (Fig. 10, bottom panels). This indicates that the suppression of DNA
replication by HDAC11 is derived from a stoichiometric relationship that exists between
the amount of Cdt1 and HDAC11 that is co-expressed.

Furthermore, these results

suggest that the inhibitory effect of HDAC11 is not due to an unrelated block to cell cycle
progression into S-phase. Higher levels of Cdt1 overexpression not only increases the
proportion of cells exhibiting >4N DNA content, but also appears to shift the distribution
of cells within the cell cycle resulting in a diminished G1 population of cells, but an
increased number of cells in S and G2-phases (Fig. 9).

This may be caused by

subpopulations of cells that have re-replicated only parts of their genome, but have not
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accumulated enough re-replication to be detected by this FACS procedure. Staining by
PI measures DNA content within a cell and this procedure is only able to detect rereplication in the subpopulation of cells that accumulates in the >4N DNA FACS
population, which ignores lesser levels of re-replication that have not generated sufficient
PI staining (Dorn et al. 2009).

To circumvent this underestimation of re-replication

levels, future experiments to analyze Cdt1-induced re-replication and suppression by
HDAC11 could utilize the more sensitive single molecule DNA fiber analysis, or fiber
spreading method.

Analysis of re-replication using this technique will allow for the

measurement of re-replication at the single replication fork level, which could more
accurately provide physiologically relevant data regarding generation of re-replication
events and the suppression of such events (Dorn et al. 2009).
Overexpression of HDAC11 alone suppresses the loading of Mcm2 on chromatin
(Fig. 11), but has no affect on the total levels of Mcm2 or Cdt1.

These results

demonstrate that HDAC11 localizes to chromosomal origins in S-phase and inhibits the
ability of Cdt1 to promote DNA replication and MCM loading. As such, and given the
positive role of HBO1 in these processes during G1 (Iizuka et al. 2008; Miotto and Struhl
2008), HDAC11 temporally opposes the function of HBO1 in regulating replication
licensing via Cdt1 interactions in S-phase.
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Fig. 9 Cdt1 Overexpression Causes Re-Replication. HeLa cells were infected for 48
hours with increasing amounts of adenovirus expressing Cdt1. Samples were processed
for flow cytometric analysis and data was analyzed with FlowJo software. Relative
amounts of each virus used to infect cells are shown and percentages indicate proportion
of cells with >4N DNA content.
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Fig. 10 HDAC11 Suppresses Cdt1-Induced Re-Replication. HeLa cells were infected
for 48 hours with increasing amounts of adenovirus expressing Cdt1 or Cdt1 and
HDAC11. Samples were processed for flow cytometric analysis and data was analyzed
with FlowJo software. Relative amounts of each virus used to infect cells are shown and
percentages indicate proportion of cells with >4N DNA content.
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Fig. 11 HDAC11 Overexpression Inhibits MCM Binding to Chromatin. HeLa cells
were infected for 24 hours with adenovirus expressing HDAC11 or control GFP. Cells
were harvested and separated into soluble and chromatin-bound fractions. Immunoblots
were performed with indicated antibodies.
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Using synchronized cell lysates separated into soluble and chromatin bound
fractions, we observed that Geminin and the faster migrating band B of HDAC11 become
chromatin bound with similar kinetics specifically during S-phase, both of which parallel
PCNA binding kinetics (Fig. 13). The slower migrating band A of HDAC11 increases
only modestly on chromatin during S-phase.

In contrast, HBO1 associates with

chromatin earlier in G1 and peaks during the time of MCM loading (6-12 hrs), consistent
with the positive role HBO1 enzymatic activity plays in promoting licensing during G1
(Iizuka et al. 2006; Miotto and Struhl 2008; Miotto and Struhl 2010). Cdt1 is chromatinbound throughout G1 and S-phase, but a slower migrating form (asterisk) becomes
visible that overlaps MCM loading kinetics (Fig. 13). The slower migrating Cdt1 is likely
to be a ubiquitinylated form of Cdt1 that is known to be degraded (Arias and Walter
2005).

Consistent with this, the slower migrating Cdt1 diminishes after its initial

appearance. The kinetics for HBO1 and HDAC11 are graphed in Figure 14. These
results are consistent with a model in which HBO1 promotes licensing in G1 and
HDAC11 prevents re-licensing during S-phase, in both cases through association with
Cdt1.
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Fig. 13 Chromatin Binding Kinetics of HDAC11. Synchronized CHO cells were
separated into soluble and chromatin-bound fractions at the indicated times and subjected
to IB with indicated antibodies. BrdU verified synchrony (data not shown).
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Fig. 14 Graphical Representation of HDAC11 Chromatin Binding Kinetics.

Although Geminin negatively influences the acetyltransferase activity of HBO1,
it does not affect the physical interaction of HBO1 with Cdt1 (Miotto and Struhl 2008).
Given the similar chromatin binding kinetics between Geminin and HDAC11, we next
determined if Geminin influenced the interaction of HDAC11 with Cdt1. Geminin and
HDAC11 can independently bind Cdt1 in vivo and in vitro (Saxena et al. 2004; Glozak
and Seto 2009), indicating that neither protein requires the other to directly bind Cdt1.
HDAC11, Geminin, and Cdt1 were transiently expressed in several combinations, and
immunoprecipitations (IP) were performed against HDAC11 or Cdt1, followed by
immunoblotting (IB) for the presence of the other expressed proteins in the IP complexes.
Without Geminin, HDAC11 and Cdt1 interact to a small degree when either protein is
pulled down in the IP step (Fig. 15, lane 5, rows A&C). Similarly, Geminin can bind
Cdt1 in the absence of HDAC11 (Fig. 15, lane 6, row D). However, when all three
proteins are co-expressed, there is a noticeable increase in the amount of HDAC11 that
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interacts with Cdt1, when either Cdt1 or HDAC11 is pulled down in the IP step (Fig. 15,
compare lanes 5&8 on rows A&C). The amount of Geminin that interacts with Cdt1 is
not influenced by HDAC11, indicating that the converse is not true (Fig. 15, compare
lanes 6&8, row D). These results demonstrate that Geminin increases the efficiency of
the HDAC11-Cdt1 interaction.
We next asked if Geminin, HDAC11, and Cdt1 could form a trimeric complex in
cells, or coexist together in a larger, multi-protein complex.

Cdt1, Geminin, and

HDAC11 were co-expressed and complexes containing Flag-HDAC11 were purified and
separated by a size-exclusion column. All three proteins co-elute in an ~700 kDa size
range (Fig. 16 fractions 15&16). Such an elution profile could be due to two separate,
but similarly-sized, large complexes in which HDAC11 is present with Geminin in one
and with Cdt1 in the other. However, this is highly unlikely given that Geminin and Cdt1
interact efficiently in cells on their own (Wohlschlegel et al. 2000; Saxena et al. 2004).
Therefore, these results indicate that all three proteins reside together in one complex
(that contains other unknown proteins), which is consistent with the fact that HDAC11
and Geminin both associate with Cdt1 in vivo during S-phase under physiologic
conditions (Wohlschlegel et al. 2000; Glozak and Seto 2009).

Since Geminin and

HDAC11 do not reduce the efficiency with which either protein can bind Cdt1 (Fig. 15),
Geminin and HDAC11 do not compete for binding to Cdt1 and can interact with Cdt1
simultaneously.

These results suggest that one function of Geminin in negatively

regulating DNA replication may derive from an inherent ability of Geminin to facilitate
HDAC11 binding to Cdt1, leading to decreased MCM loading.
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Fig. 15 Geminin Enhances the Cdt1-HDAC11 Interaction. Indicated proteins (top)
were expressed in 293T cells and subjected to immunoprecipitation (IP) and
immunoblotting (IB) analysis as indicated on right. IP and IB analyses were performed
with anti-tag antibodies. Representative of three separate experiments with similar
results.
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Fig. 16 Geminin, HDAC11, and Cdt1 Interact in a Single Complex. Flag-HDAC11,
HA-Geminin, and Myc-Cdt1 were co-expressed in 293T cells followed by anti-Flag
purification. Eluates containing Flag-HDAC11 complexes were separated on a size
exclusion column and analyzed by IB.

Cdt1 Targeting Induces Large-Scale Chromatin Decondensation
Cdt1 recruits two histone modifying enzymes, HBO1 and HDAC11, that regulate
MCM loading and DNA replication in an opposing manner.

The timing of the

association of these enzymes with replication origins coincides with the presence or
absence, respectively, of acetylated histone H4 (Miotto and Struhl 2010). Although the
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H4 acetylation is known to be required for MCM recruitment (Miotto and Struhl 2010),
the mechanism by which it facilitates this is unknown. We hypothesized that the ability
of Cdt1 to differentially recruit these enzymes produced higher-order chromatin structural
changes that facilitate or inhibit MCM recruitment via altered chromatin accessibility.
Currently, there is no technological means to assess changes to higher-order chromatin
structure at chromosomal origins.

However, to test this concept, we employed an

innovative chromatin remodeling system that assesses the ability of proteins to generate
changes to higher-order chromatin structure (Tumbar et al. 1999; Alexandrow and
Hamlin 2005). This system utilizes a CHO-derived cell line (A03_1) that contains a 90
Mb homogeneous staining region (HSR) that was engineered through stable insertion and
amplification of a Lac-operator(LacO)/DHFR vector (final HSR contains ~1600 such
vectors).

The presence of LacO sites throughout the HSR allows for microscopic

visualization of chromatin structural changes that occur following targeting of LacI-fused
proteins of interest (Fig. 17).

In its normal unperturbed state, the HSR adopts a

condensed dot-like structure that is heterochromatic in nature (Li et al. 1998). However,
targeting proteins that recruit chromatin remodeling enzymes elicits dramatic changes in
the HSR structure, resulting in clearly observable, highly decondensed HSRs occupying
large portions of the nucleus (Tumbar et al. 1999; Alexandrow and Hamlin 2005). This
system provides insight into regulation of higher-order chromatin dynamics that cannot
be analyzed by any other current experimental means.
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Fig. 17 Schematic of in vivo Chromatin Remodeling System.
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The mechanisms underlying chromatin remodeling in this system derive from
specific, physiologically relevant events involved in altering chromatin structure by
targeted proteins. Several transcription factors, including p53, E2F1, BRCA1, VP16, and
ER, promote decondensation via histone acetylation, H2AX phosphorylation, and
recruitment of chromatin modifying enzymes (Tumbar et al. 1999; Ye et al. 2001; Nye et
al. 2002). The replication protein, Cdc45, promotes decondensation via Cdk2 recruitment
and H1 phosphorylation(Alexandrow and Hamlin 2005).

In contrast, some proteins

promote condensation (Verschure et al. 2005), while others produce no changes to the
HSR structure (remains condensed).

Fig. 18 VP16 induces chromatin remodeling, but Cdc6 and LacI do not. LacI-VP16,
LacI alone, or LacI-Cdc6 were transiently expressed in A03_1 cells, followed by IF with
anti-LacI and Texas Red to detect open/decondensed (‘O’) or closed/condensed (‘C’)
HSRs. Nuclei were stained with DAPI.
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To determine if Cdt1 can promote large-scale decondensation of the HSR, Cdt1
was fused to LacI and transfected into A03_1 cells. As controls, LacI-VP16, LacI-Cdc6,
or the LacI DNA binding domain (DBD) alone were also expressed. Figure 18 shows
that LacI-VP16 promotes large-scale decondensation, while LacI-Cdc6 and LacI-DBD do
not, consistent with previous findings (Tumbar et al. 1999; Alexandrow and Hamlin
2005). Targeting Cdt1 to the HSRs produces a dramatic decondensation of the chromatin
(Fig. 19).

Fig. 19 Cdt1 Induces Chromatin Remodeling. LacI-Cdt1 was transiently expressed in
A03_1 cells, followed by IF with anti-LacI and Texas Red to detect open/decondensed
(‘O’) or closed/condensed (‘C’) HSRs. Nuclei were stained with DAPI.
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All proteins express similarly (Fig. 20), and the fact that LacI alone expresses
significantly higher indicates that targeting proteins does not itself elicit changes to the
HSR due to crowding or related effects.

As described previously (Alexandrow and

Hamlin 2005), we assigned 'open' versus 'closed' status to the visual appearance of the
HSRs using objective criteria. Open structures clearly display large, decondensed HSRs
that occupy more than 10% of the nuclear area. Closed HSRs are obvious condensed
structures that failed to unfold and typically cover less than 5% of the nuclear area. In all
analyses, some HSRs are visible that are dot-like in appearance, but somewhat larger in
size (~5-10% of nuclear area). We refer to the latter as Indeterminate, since classifying
such HSRs is highly subjective.

Using these objective criteria, ~2/3 of LacI-Cdt1

targeted HSRs become decondensed, similar to that for VP16 (Table I). In addition to
being enriched at the HSRs due to LacI targeting, the LacI-Cdt1 protein is also localized
throughout the nucleus and not in the cytoplasm (Fig. 21), demonstrating that the
localization of ectopic Cdt1 is regulated by physiologic mechanisms. We conclude from
these results that targeting Cdt1, but not Cdc6, to chromosomal regions in vivo produces a
clearly observable and robust decondensation of higher-order chromatin structure.
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Fig. 20 Expression Levels of LacI-Fusion Proteins. Immunoblot of LacI-fusion protein
expression for the results in Table 1.

Fig. 21 LacI-Cdt1 Localizes to the Nucleus. Anti-LacI immunofluorescence separated
from DAPI showing LacI-Cdt1 present throughout the nucleus.
62

63

Cdt1-Induced Chromatin Unfolding Occurs During G1
We reasoned that, if chromatin unfolding induced by Cdt1 were physiologically
involved in creating chromatin access for loading MCMs, then such unfolding should
occur during G1. We determined the cell cycle phase at the time when decondensation
occurred after LacI-Cdt1 targeting. To indicate S-phase cells, BrdU staining was used,
and cells that were in G2 and/or M-phases were identified by anti-H1-phospho (H1-P)
staining, since H1-P levels are highest at these times (Lu et al. 1994; Alexandrow and
Hamlin 2005).

LacI-Cdt1-induced open HSRs were found almost exclusively in

transfected cells that neither displayed BrdU nor H1-P staining (Fig. 22). These results
indicate that the cells are primarily in G1 (but early S-phase is also possible) at the same
time that the transient LacI-Cdt1 protein is expressed and open HSRs are being
generated. Interestingly, closed HSRs correlated in the opposite manner (i.e., with S, G2,
or M-phase cells). Thus, chromatin unfolding by Cdt1 occurs in G1, when Cdt1 is known
to function in MCM loading.
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Fig. 22 Cdt1-Induced Chromatin Decondensation Occurs in G1-phase. LacI-Cdt1
was expressed in A03_1 cells for 24 hours, then pulsed with BrdU. Anti-BrdU and antiH1-P staining was used to relate the index of BrdU-negative and H1-P-positive cells to
the open or closed HSR status.
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Geminin Efficiently and Specifically Suppresses
Cdt1-Induced Chromatin Unfolding
Since Geminin is a physiologic inhibitor of Cdt1 at high Geminin:Cdt1 ratios
(Lutzmann et al. 2006), we asked if the decondensation by Cdt1 were Geminin sensitive.
Chromatin decondensation assays were performed using a 1:1 ratio of Geminin:Cdt1
vectors, or a higher 5:1 ratio. Relative protein expression is shown in Figure 23.

Fig. 23 Expression Levels of LacI-Cdt1 and HA-Geminin.
HA-Geminin was
transfected to a 5:1 or 1:1 plasmid ratio with LacI-Cdt1 and relative protein expression
was verified by IB.
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Compared to LacI-Cdt1 + pcDNA3 control, 1:1 ratios of Geminin:Cdt1 did not
alter the amount of decondensation produced by Cdt1 (Table I). However, co-expression
of Geminin at a 5:1 ratio significantly suppressed the ability of Cdt1 to decondense
chromatin (Table I and Fig. 24, top panels).

Under these conditions, we noticed the

appearance of a number of very small, but slightly decondensed HSRs, which we define
as 'small-open' (Fig. 24, top left panel).

We considered these ‘small-open’ HSRs as

closed, since they have clearly not succeeded in becoming large decondensed HSRs that
are normally seen with Cdt1 expressed alone (compare Fig. 24, top panels vs. bottom
panels). Chromatin unfolding induced by Cdc45 or VP16 was not sensitive to inhibition
by Geminin (Table I), indicating that the inhibitory effect of Geminin toward Cdt1 is
specific and is not due to global effects that suppress chromatin remodeling mechanisms.
These results demonstrate a novel effect of Geminin in modulating chromatin
accessibility through its interaction with Cdt1.
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Fig. 24 Geminin Inhibits Cdt1-Induced Chromatin Unfolding. Examples of smallopen and closed HSRs resulting from transfection of a 5:1 plasmid ratio of HAGeminin:LacI-Cdt1.
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Chromatin Unfolding by Cdt1 is Required for Cell Proliferation
and Efficient DNA Re-Replication
We next determined the region within Cdt1 that is required for promoting
chromatin unfolding, and then tested for biological effects of loss of this domain.
Carboxy-terminal truncations of Cdt1 were generated and tested for chromatin unfolding
ability, and it was found that a region in the middle of Cdt1 is required for chromatin
decondensation. A deletion mutant of Cdt1 was made that lacked specifically this region
(Fig. 25) and was deficient for chromatin unfolding (Fig. 26).

Fig. 25 Deletion Mutant of Cdt1 that is Defective for Chromatin Remodeling.
Diagram showing location of Cdt1 chromatin remodeling domain.
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Fig. 26 Cdt1 Deletion Mutant Does Not
Cause Chromatin Unfolding. Chromatin
unfolding ability of Cdt1-(Δ201-355) was
tested. LacI-Cdt1-(Δ201-355) was expressed
in A03_1 cells for 24 hours before analysis.

Stable expression of Cdt1-(Δ201-355) was found to significantly inhibit the
ability of cells to proliferate relative to wt-Cdt1 (Fig. 27). Intriguingly, a previous report
analyzing Cdt1 mutant alleles found that Cdt1 lacking this region is 25-60% less efficient
at promoting re-replication versus multiple Cdt1 alleles that contain this region (Teer and
Dutta 2008). In agreement with this prior study, Cdt1-(Δ201-355) is 25-50% reduced in
re-replication ability versus wt-Cdt1 (Fig. 28).

The reason Cdt1 re-replication is not

completely diminished is because all alleles containing the amino-terminus of Cdt1 will
induce re-replication due to dilution of Cdt1 degradation machinery by competitive
binding, allowing endogenous Cdt1 to induce re-replication in addition to the exogenous
protein being tested (Teer and Dutta 2008).

As such, we conclude from these

experiments that the chromatin unfolding function of Cdt1 is required for sustained cell
cycle progression due at least in part to a necessity for this region to promote efficient
DNA replication.
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Fig. 27 Cdt1 Deletion Mutant Inhibits Cell Survival. Colony forming assays were
performed in CHO cells to test the ability of wt-Cdt1 and Cdt1-(Δ201-355) to suppress
colony growth. Stable selection for protein expression lasted 14 days, followed by
Giemsa staining.
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Fig. 28 Cdt1 Deletion Mutant is Inhibited in Causing Re-Replication. HeLa cells
were used as in Figure 8 to determine the re-replication induction ability of Cdt1(Δ201-355) compared to wt-Cdt1, except 48 hour transfections were used. Results from
two experiments are shown, compared to wt-Cdt1 normalized to 100% re-replication
ability.

Chromatin Decondensation by Cdt1 Stimulates MCM Recruitment
We next asked if chromatin decondensation by Cdt1 stimulated the recruitment of
endogenous MCMs. Chromatin unfolding assays were performed in which LacI-Cdt1
was expressed, followed by co-staining against LacI (to identify open or closed HSRs)
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and Mcm4 or Mcm7. Figure 29 shows that endogenous Mcm4 and Mcm7 both become
noticeably enriched at Cdt1-decondensed HSRs.

In contrast, HSRs decondensed by

BRCA1 or VP16 did not enhance Mcm7 recruitment (Fig. 30).

We also found that

PCNA became enriched at Cdt1-decondensed HSRs (Fig. 31), but the effect was not
dramatic and only occurred in a small percentage of such samples (<10%, data not
shown).

Fig. 29 Cdt1-Induced Chromatin Unfolding Stimulates MCM Recruitment. Open
HSRs following LacI-Cdt1 expression were co-stained by IF with antibodies to LacI,
Mcm7, or Mcm4. Arrows indicate open HSRs and enrichment of endogenous MCMs.
A03_1 cells were used and transfections lasted 24 hours.
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Relative to BRCA1 and VP16, where MCM co-localization was far less frequent
and not dependent on chromatin decondensation, ~1/3 of Cdt1-decondensed HSRs
displayed enriched MCM recruitment (Fig. 30). Only a small number (5%) of Cdt1bound HSRs that failed to open recruited MCMs. This result was obtained in more than
6 separate experiments (data not shown, but see below). This consistent observation
probably derives from our necessary use of asynchronous populations for these analyses.
The machinery involved in MCM loading is only available during a certain period of time
in the cell cycle, and in cells released from quiescence, MCM loading occurs in the latter
~1/3 of G1 (Mukherjee et al. 2009). Cdt1-induced decondensation occurs in G1 (Fig. 22)
and MCM recruitment is seen in only ~1/3 of these, which correlates with such a
prediction.
A simple explanation for why MCMs are enriched at the HSRs upon Cdt1
targeting could derive from the fact that Cdt1 can bind to MCMs (Tanaka and Diffley
2002; Yanagi et al. 2002; Teer and Dutta 2008). However, Cdt1-bound HSRs that fail to
open are not efficiently enriched with MCMs (Fig. 32), indicating that the presence of
Cdt1 alone at these chromosomal sites is not sufficient for MCM recruitment. Since a
significant number of Cdt1-decondensed HSRs are not enriched for MCMs, the
recruitment of MCMs does not itself produce a crowding effect that causes the unfolding.
We conclude from these results that Cdt1-induced decondensation is a prerequisite for
stimulating MCM recruitment.
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Fig. 30 BRCA1 and VP16 Chromatin Remodeling Does Not Recruit Endogenous
MCMs. Open HSRs following LacI-BRCA1 or LacI-VP16 expression were co-stained
by IF with antibodies to LacI or Mcm7. Arrows indicate open HSRs and enrichment of
endogenous MCMs. A03_1 cells were used and transfections lasted 24 hours.
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Fig. 31 PCNA can be Recruited to Chromatin
Unfolded by Cdt1. Open HSRs following LacICdt1 expression were co-stained by IF with
antibodies to LacI and PCNA. Arrows indicate open
HSRs and enrichment of endogenous PCNA. A03_1
cells were used and transfections lasted 24 hours.

Fig. 32 Quantification of
Endogenous Mcm7
Recruitment. This graph
depicts the proportion of
HSRs that demonstrated
colocalization with
endogenous Mcm7 as a
result of LacI-Cdt1, LacIBRCA1, or LacI-VP16
targeting.
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HBO1 and HDAC11 Regulate Cdt1-Induced Chromatin Unfolding
Given that HBO1 and HDAC11 are known histone/chromatin modifiers (Gao et
al. 2002; Doyon et al. 2006), we asked whether these factors could modulate Cdt1induced chromatin decondensation. We verified that HDAC11 and Cdt1 interact in vivo
in reciprocal co-IP experiments (Fig. 33, left). Similarly, HBO1 and Cdt1 interact in vivo
(Fig. 33, right).

Fig. 33 Cdt1 Interacts with HDAC11 and HBO1 in vivo. IP-Western assays were
performed using the indicated proteins and anti-tag antibodies. 293T cells were used and
transfections lasted 24 hours.
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LacI-Cdt1 was co-expressed with HDAC1, HDAC11, HBO1-wt, or HBO1G485A
(catalytically-inactive), and the decondensation potential of Cdt1 was determined for
each condition. Similar amounts of LacI-Cdt1 expression were achieved, but more LacICdt1 was expressed with HBO1G485A (Fig. 34).

Similar expression of HDAC1 and

HDAC11 was achieved, while HBO1G485A expressed slightly less well compared to
HBO1-wt.

Fig. 34 Expression Levels of LacI-Cdt1 with Flag-HDAC1, Flag-HDAC11, HAHBO1-wt, and HA-HBO1-Mutant. Immunoblot of indicated proteins showing their
relative protein expression for the results in Table 2 and 3.
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HDAC1 and HBO1-wt do not alter the ability of Cdt1 to induce chromatin unfolding
(Table II).

However, HDAC11 dramatically suppresses the ability of Cdt1 to cause

decondensation, producing a concomitant increase in closed HSRs.

Despite being

expressed at lower levels relative to HBO1-wt, and in the presence of higher amounts of
LacI-Cdt1, HBO1G485A also suppresses Cdt1-induced decondensation.

In comparison,

HDAC1, HDAC11, HBO1-wt, and HBO1G485A do not affect VP16-induced
decondensation (Table II). We conclude from these results that HBO1 normally performs
a positive role specifically in Cdt1-induced chromatin unfolding, while HDAC11 is a
strong and specific inhibitor of the decondensation by Cdt1. Furthermore, these results
indicate that the effects of HBO1 and HDAC11 on chromatin remodeling by Cdt1 are not
due to global cellular changes that affect chromatin remodeling in general.
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HBO1 and HDAC11 Influence MCM Recruitment to Cdt1-Targeted HSRs
We next asked if HBO1 or HDAC11 influenced the level of MCM recruitment to
Cdt1-targeted HSRs. Chromatin remodeling assays were performed as above, but costained and quantified for enrichment of endogenous Mcm4 or Mcm7.

HDAC1 and

HBO1-wt again had no effect on the ability of Cdt1 to cause chromatin decondensation
(data not shown), nor did either protein significantly alter the amount of Mcm4 or Mcm7
that was enriched overall (Fig. 35 and Table III). In both cases, MCM enrichment was
primarily associated with HSRs that had undergone a decondensation event (Fig. 35). In
contrast, HDAC11 and HBO1G485A again inhibited the ability of Cdt1 to cause
decondensation (producing closed HSRs; data not shown), and this was associated with a
significant reduction in total MCM enrichment (Fig. 35 and Table III).

For both

HDAC11 and HBO1G485A, any enrichment of MCMs was almost exclusively associated
with the small percentage of HSRs that had unfolded under these conditions (data not
shown). We conclude from these results that HBO1 is normally required for efficient
chromatin unfolding and MCM recruitment by Cdt1, while HDAC11 is a potent and
specific inhibitor of the ability of Cdt1 to cause decondensation and MCM recruitment.
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Fig. 35 HDAC11 and HBO1-Mutant Inhibit Cdt1-Induced Chromatin Unfolding
and Subsequent Endogenous MCM Recruitment. Examples of co-localizing Mcm7
(or lack thereof) in cells expressing indicated combination of proteins. Samples were
processed by IF with indicated antibodies as in Figure 29. Open/decondensed (‘O’),
closed/condensed (‘C’) HSRs. Quantitative results are presented in Table 3.

Chromatin Decondensation and MCM Recruitment by
Cdt1 Involve Histone H4 Acetylation
Recruitment of MCMs to chromosomal origins depends on HBO1
acetyltransferase activity toward histone H4 (Miotto and Struhl 2010). We reasoned that
histone H4 modifications played a role in the Cdt1-induced decondensation and MCM
recruitment to the HSRs due to the involvement of HBO1 and HDAC11 in this process.
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Although we predicted that H4 acetylation on residues K5, K8, or K12 should be
increased at the decondensed HSRs following Cdt1 targeting, we observed no stable
association of such modifications with the unfolded HSRs (data not shown).

H4

acetylation is known to be a transient event at origins (Miotto and Struhl 2010), which
likely explains our inability to observe stable H4 modifications. However, to show that
H4 acetylation does play a functional role in the decondensation process, we took
advantage of the ability of the Set8 histone methylase H4 binding domain (HBD) to
interact with H4 tails and block their acetylation (Yin et al. 2008; Miotto and Struhl
2010).

Fig. 36 Expression of FlagHDAC1 and Flag-Set8-HBD.
Anti-Flag immunoblot showing
the relative transient expression
of Flag-HDAC1 versus FlagSet8-HBD. Panels are from the
same immunoblot/exposure.
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Set8-HBD, HDAC1, or GST was co-expressed with LacI-Cdt1, and the ability of
Cdt1 to promote chromatin decondensation and MCM recruitment was determined. As
described above, HDAC1 does not affect the ability of Cdt1 to unfold chromatin and
promote MCM recruitment. However, although Set8-HBD expresses less efficiently than
HDAC1 (Fig. 36), co-expression of Set8-HBD significantly reduces the ability of Cdt1 to
promote decondensation relative to HDAC1 (Figs. 35&37 and Table II). Co-expression
of GST similarly has no effect on Cdt1-induced chromatin unfolding (Fig. 37 and Table
II) and MCM recruitment (Fig. 37 and Table III). These results strongly suggest that, at
least in a transient manner, acetylation of H4 tails is necessary for Cdt1 to induce
chromatin unfolding and stimulate MCM recruitment in vivo.

These findings are

consistent with prior studies showing that HBO1 catalytic activity and the resultant H4
acetylation at origins are required for MCM recruitment by Cdt1 (Miotto and Struhl
2010), but now provide mechanistic evidence that such H4 acetylation promotes
chromatin accessibility and fluidity that facilitates the loading of the MCM complex.
Intriguingly, the amount of suppression elicited by Set8-HBD is very similar to that
caused by HBO1G485A (Table II), as expected if H4 acetylation by HBO1 plays a
functional role in Cdt1-induced chromatin unfolding. However, neither Set8-HBD nor
HBO1G485A are as potent as HDAC11 at suppressing Cdt1-induced unfolding, suggesting
that additional modifications, perhaps on other histone subunits, are likely involved in
this process.
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Fig. 37 Blocking Histone H4 Acetylation Prevents Cdt1-Induced Chromatin
Decondensation and Endogenous MCM Recruitment. Examples of co-localizing
Mcm4 (or lack thereof) in A03_1 cells expressing indicated proteins. Open/decondensed
(‘O’), closed/condensed (‘C’) HSRs. Quantitative results are presented in Table 3.
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Chromatin at Endogenous Origins of DNA Replication
is More Accessible during G1 versus S-phase
Our results suggest that chromatin at origins of DNA replication will be more
accessible in G1 when MCMs are loading, due to Cdt1 and HBO1 activities, but less
accessible during S-phase, due to HDAC11 recruitment by Cdt1. Intriguingly, at least
three reports in the literature have shown this situation to be true at higher eukaryotic
origins. The chromatin at the GAS41 origin in chicken cells and the β-globin origin in
human cells displays increased DNase I hypersensitivity during G1, but becomes less
accessible to nuclease digestion in S-phase (Djeliova et al. 2002; Zimmermann et al.
2007). Similarly, chromatin at the ori-β and ori-γ origins in CHO cells is more accessible
and sensitive to micrococcal nuclease in G1 versus S-phase (Pemov et al. 1998).
We determined if the same were true at the MCM4 and Lamin B2 origins in
human cells. HaCaT cells were synchronized and released into the cell cycle, and intact
chromatin was isolated in late-G1 and S-phase and subjected to controlled DNase I
digestion followed by qPCR analysis (Fig. 38).

Less accessible chromatin at these

origins reduces DNase I digestion, resulting in more substrate available for qPCR.
Relative to late-G1, the MCM4 and Lamin B2 origins are both less accessible to DNase I
in S-phase as indicated by the increased qPCR substrate availability from these time
points. Thus, six higher eukaryotic endogenous replication origins analyzed by different
methods (indirect end labeling or qPCR) display increased chromatin accessibility in G1,
but less accessibility during S-phase. Our results now provide a molecular explanation
for this differential chromatin accessibility at replication origins that involves Cdt1-
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modulated control over higher-order chromatin structure via temporal recruitment of
HBO1 and HDAC11.

Fig. 38 Chromatin at Endogenous DNA Replication Origins is More Accessible
During G1-phase than in S-phase.
HaCaT cells were synchronized by serum
deprivation and verified by BrdU incorporation as in Figure 8. qPCR was performed on
DNase I treated chromatin samples from the indicated time points. Results were
normalized against input chromatin from each time point that was not treated with DNase
I, to account for increases in DNA levels during S-phase. Assays were performed in
triplicate to generate error bars.
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CHAPTER 4

DISCUSSION AND FUTURE DIRECTIONS

Cdt1-Induced Chromatin Decondensation Mediates MCM Loading
We present evidence for a novel form of replication licensing control that involves
the ability of Cdt1 to modulate chromatin accessibility through the temporal recruitment
of HBO1 and HDAC11 (modeled in Fig. 39). In G1, Cdt1 (by ORC interaction) recruits
HBO1 to replication origins, resulting in acetylation of H4 within the origin regions
(Miotto and Struhl 2008; Miotto and Struhl 2010). We show here that at least one effect
of this acetylation is an increase in chromatin accessibility that is required for MCM
recruitment. HBO1 catalytic activity is required for MCM loading at origins (Miotto and
Struhl 2010), and HBO1 stimulates Cdt1-dependent re-replication (Miotto and Struhl
2008). Upon entering S-phase, de novo MCM recruitment is blocked, and we show here
that HDAC11 contributes to this process. HDAC11 interacts with Cdt1 and localizes to
replication origins specifically in S-phase, and HDAC11 is capable of catalyzing the
removal of acetylation from H4 (Gao et al. 2002). Consistent with this, H4 acetylation
decreases at replication origins during S-phase (Miotto and Struhl 2010).
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HDAC11

potently inhibits the ability of Cdt1 to cause chromatin decondensation, suppresses the
recruitment of MCMs, and blocks Cdt1-induced re-replication.

As such, HDAC11

directly opposes the functions of Cdt1 and HBO1 in promoting replication licensing,
thereby producing a ‘yin-yang’ relationship between HBO1 and HDAC11.

The

mechanism underlying this relationship derives from the ability of HBO1 to promote
chromatin decondensation for MCM loading in G1, followed by the recruitment of
HDAC11 in S-phase, which produces chromatin inaccessibility and prevents MCM
loading. Such a model is supported by temporal changes in chromatin accessibility at
endogenous origins in higher eukaryotic cells shown here and by others (Pemov et al.
1998; Djeliova et al. 2002; Zimmermann et al. 2007), where origins are more accessible
in G1 and transition to less accessible chromatin organization in S-phase.
Geminin is a physiologic inhibitor of Cdt1 during S-phase (Wohlschlegel et al.
2000). While the binding of Geminin to Cdt1 reduces the ability of Cdt1 to interact with
the MCM complex (Yanagi et al. 2002; Cook et al. 2004), Geminin has been found to
also influence the function of HBO1 in association with Cdt1. Geminin does not alter the
interaction of HBO1 with Cdt1 (Miotto and Struhl 2008), but instead inhibits the
acetyltransferase activity of HBO1 (Miotto and Struhl 2010). We present evidence here
that another mechanism whereby Geminin modulates Cdt1 function is through enhanced
HDAC11 recruitment to Cdt1 (modeled in Fig. 39). Thus, Geminin indirectly suppresses
H4 acetylation at origins by inhibiting HBO1 acetyltransferase activity and by promoting
the recruitment of HDAC11.

As a result, Geminin produces decreased chromatin

accessibility that blocks MCM loading, which is supported by our observation that
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Geminin potently and specifically suppresses chromatin decondensation induced by Cdt1.

Fig. 39 Working Model.
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Currently, we do not know how Geminin modulates HBO1 HAT activity or HDAC11
association with Cdt1. One possibility is that Geminin directly influences HBO1 activity
and interactions of HDAC11 with Cdt1, although Geminin does not compete with either
protein for Cdt1 binding. However, an alternative explanation may derive from Gemininregulated recruitment of unknown factors that themselves control these events. Clearly,
further investigation is required to answer these questions.
There is currently no technological means to observe large-scale chromatin
structural changes at specific single genomic loci in mammalian cells (i.e., origins).
Although we have utilized an innovative, but engineered, chromatin remodeling system
to address this question, several lines of evidence indicate that the events observed using
this system recapitulate those occurring at origins, but at a macroscopic level. Chromatin
decondensation induced by Cdt1 occurs during G1 and is sensitive to Geminin in a highly
specific manner.

Cdt1-induced decondensation involves H4 acetylation during the

process of unfolding, is dependent on HBO1 function, and is sensitive to HDAC11
inhibition. In both cases, these enzymes elicit their effects specifically for chromatin
decondensation derived from Cdt1. MCM recruitment is clearly observed as a specific
result of Cdt1-induced decondensation, and is inhibited by mutant HBO1 and HDAC11
in a specific manner. As described above, Cdt1, HBO1, and H4 acetylation dependency
for MCM recruitment is also true at origins specifically during G1. HDAC11 associates
with origins during S-phase (and not in G1), when H4 acetylation decreases and origin
access would be predicted to be blocked, and HDAC11 reduces Cdt1-induced re-
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replication potential and suppresses genomic MCM loading.

Most importantly, and

highly consistent with our findings, endogenous DNA replication origins display
temporal changes in chromatin organization that produce more open and accessible
conditions during G1, but transition to a less accessible chromatin state in S-phase
(results herein, and references (Pemov et al. 1998; Djeliova et al. 2002; Zimmermann et
al. 2007). Collectively, such results provide a strong argument that our observations in
vivo at this engineered locus represent physiologic events occurring during replication
licensing that cannot be seen by any other current experimental approach. Importantly,
these results indicate that chromatin accessibility is at least one mechanism whereby
Cdt1, HBO1, HDAC11, and Geminin regulate replication origins via H4 acetylation
changes.

Chromatin Remodeling in DNA Replication
In yeast and flies, the HBO1 homologs GCN5 and Chameau, respectively, induce
acetylation of histones globally and near origins, which promotes origin firing (Vogelauer
et al. 2002; Aggarwal and Calvi 2004).

In contrast, Rpd3, which is homologous to

HDAC11, decreases acetylation and reduces origin activity (Vogelauer et al. 2002;
Aggarwal and Calvi 2004). Similarly, the timing of activation of the β-globin origin in
mammalian cells is influenced by its acetylation state. Whereas acetylation of the βglobin is associated with earlier firing, targeting HDAC2, which is related to HDAC11,
renders the origin late-firing (Goren et al. 2008).

Our results provide a mechanistic

explanation for these studies of replication origin control by histone acetylation in which
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the acetylation influences chromatin accessibility for MCM loading. Although we do not
know biochemically how H4 acetylation promotes chromatin unfolding, at least two
possibilities are likely. First, histone H4 acetylation has been shown to directly enhance
chromatin accessibility via structural changes (Shogren-Knaak et al. 2006), consistent
with what we have observed herein. Second, histone acetylation may recruit
bromodomain containing proteins that facilitate the chromatin unfolding (Strahl and Allis
2000).

Neither of these mechanisms is mutually exclusive with the other and it is

possible both may contribute to chromatin structural changes at origins. Finally, it is
likely that chromatin modifying enzymes other than HBO1 and HDAC11 are involved in
regulating replication origins. For example, SNF2H and WSTF have been shown to copurify with Cdt1 and differentially bind to chromatin depending on histone tail
modifications (Hakimi et al. 2002; Sugimoto et al. 2008).

Cdt1 and Cancer
Cdt1 is oncogenic and overexpressed, sometimes via amplification, in several
human cancers, including lung and colon carcinomas, melanomas, and some leukemias
and lymphomas (Arentson et al. 2002; Seo et al. 2005; Liontos et al. 2007).
Overexpression of Cdt1 alone in NIH3T3 fibroblasts leads to the formation of tumors in
Rag2 null mice (Arentson et al. 2002). Furthermore, the T-cell-directed overexpression
of Cdt1 in the absence of p53 in transgenic mice leads to the development of
lymphoblastic lymphoma, further demonstrating the impact of deregulated Cdt1 in
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contributing to tumorigenecity (Seo et al. 2005).

These observations indicate that

increased Cdt1 expression and deregulation of preRC licensing can lead to tumorigenesis.
A normal cell cycle involves a single round of DNA replication, and the
oncogenic nature of Cdt1 derives from its ability to promote MCM loading and rereplication, the result of which is an increase in genomic instability (Vaziri et al. 2003;
Liontos et al. 2007). Decreasing levels of Geminin, a biological inhibitor of Cdt1, also
results in re-replication, suggesting the functional balance of preRC components is
important in preventing over-replication of the genome (Saxena and Dutta 2005). The
acute overexpression of Cdt1 and Cdc6 leads to re-replication and DNA damage, most
notably double strand breaks, which initially result in senescence and apoptosis (Liontos
et al. 2007).

However, prolonged growth stimulus by Cdt1 and Cdc6 eventually

overcomes these antitumor barriers and the induced re-replication leads to recombination
and genomic instability that selects for cell populations with aggressive phenotypes
(Liontos et al. 2007).

Chromosomal analysis of tumor cells resulting from Cdt1

overexpression in NIH3T3 cells demonstrated a multitude of chromosomal abnormalities
including chromosome breaks and gaps, polyploidy, and chromosome end associations
(Seo et al. 2005). Furthermore, increased Cdt1 and Cdc6 expression in a subset of mantle
cell lymphomas was highly associated with the formation of secondary chromosomal
abnormalities compared to MCL populations without an unbalanced increase in DNA
replication licensing proteins (Pinyol et al. 2006). These findings demonstrate that Cdt1
deregulation result in re-replication and subsequent loss of genome integrity, which
correlate with tumorigenesis.

95

The genetic instability caused by Cdt1-induced re-replication results in the
transformation of a cell by disrupting the normal context of chromosomal regulation of
genes responsible for growth control, apoptosis, and metastasis.

A diverse array of

genetic alterations can potentially lead to changes in expression of such proteins that are
involved in oncogenesis. Aneuploidy, which results in large changes in genetic material
by gains or losses of entire chromosomes or chromosomal domains, is one such result of
genomic instability. The loss of large genomic regions could result in the deletion of
tumor suppressor proteins, while chromosomal duplication has the potential to increase
gene dosage of oncogenes (Lengauer et al. 1998; van Gent et al. 2001). Re-replication
can also lead to the amplification of specific genomic regions, potentially resulting in the
onion-skin model of amplification (Bostock 1986).

The result of this type of re-

replication is increased gene copy number, which would have an impact in the
tumorigenic potential of a cell if oncogenes were amplified (Green et al. 2010). Other
ramifications of these re-replication events include DNA damage and double strand
breakage, which can perpetuate genomic instability (Green and Li 2005).

Errors in

double stranded break repair, normally performed by non-allelic homologous
recombination and non-homologous end joining, can lead to compromised genetic
stability culminating in loss or gains of genomic material and potentially chromosomal
translocations (Ferguson et al. 2000; Ferguson and Alt 2001; Khanna and Jackson 2001).
Translocations represent gross genomic alterations that can potentially give rise to
tumorigenesis (Ferguson and Alt 2001). In this process, chromosomes are rearranged,
whereby large chromosomal regions are exchanged and fused, which can deregulate
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oncogenes or tumor suppressors and cause transformation (Lengauer et al. 1998; van
Gent et al. 2001)
Our results suggest that one molecular mechanism mediating Cdt1’s ability to
promote re-replication is the temporal recruitment of histone modifying enzymes that
alter chromatin structure and thereby modulate chromatin accessibility. Excessive levels
of Cdt1 will inappropriately cause chromatin decondensation cycles at origins, allowing
re-loading of MCMs within one cell cycle. The resultant re-initiation of DNA replication
within S-phase produces genomic instability, and as such, provides a novel molecular
explanation for how tumorigenesis can occur due to changes in chromatin accessibility at
replication origins. This model of deregulated chromatin access is supported by the
findings that the expression of the histone acetyltransferase, HBO1, is elevated in several
human carcinomas (Iizuka et al. 2009).
Since the overexpression of licensing factors, in particular Cdt1, can lead to
oncogenic transformation, an important question then arises with respect to HDAC11 and
its potential role as a tumor suppressor. Since we have demonstrated that HDAC11 is
recruited to replication origins in S-phase and acts to inhibit Cdt1 function, it stands to
reason that disruption of HDAC11 expression or function would lead to Cdt1-induced rereplication and subsequent genomic instability. To test this hypothesis, acute knockdown
of HDAC11 protein levels by RNAi (or the utilization of a catalytically-dead HDAC11
mutant) would be useful to assess its ability to regulate the re-replication caused by Cdt1
as determined by FACS or single molecule DNA fiber analysis. Stable knockdown of
HDAC11, for example by shRNA or generation of a HDAC11 null mouse, would also
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provide great insight into its ability to act as a tumor suppressor. One may expect that
such cells lacking HDAC11 could be more prone to tumorigenesis.

Long-term

suppression of HDAC11 expression could potentially lead to cytogenetically abnormal
cells harboring chromosomal aberrations reflective of long-lived genomic instability,
which would be identified by FISH analysis.

Furthermore, such stable knockdowns

could also be analyzed by the single molecule DNA fiber analysis to measure low level
re-replication.

Since Cdt1 is regulated, both in terms of function and stability, by

multiple mechanisms in addition to HDAC11, it is possible that HDAC11 impairment
alone would not cause re-replication as the redundancy in Cdt1 regulation would be
sufficient in preventing this. To this end, it would be beneficial to analyze HDAC11
knockdowns with respect to their tolerance of Cdt1 overexpression when compared with
control, normal HDAC11 cells.

For example, HDAC11 null cells may be more

susceptible to Cdt1-induced re-replication than normal cells.

Moreover, since Cdt1

overexpression in NIH3T3 cells and p53 null transgenic mice lead to tumorigenesis
(Arentson et al. 2002; Seo et al. 2005), and we observe that HDAC11 inhibits Cdt1induced re-replication, co-overexpression of HDAC11 with Cdt1 in the NIH3T3 cells or
transgenic mouse model system may be inhibited in tumor formation. It would be of
great interest to pursue these investigations to determine if HDAC11 can indeed function
as a tumor suppressor.
Two mechanisms of cell cycle arrest previously thought to be independent, were
recently shown to be causally related. Replicative stresses and their resultant genomic
instability trigger DNA damage responses and cell cycle senescence via ATM and Chk2
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(Gorgoulis et al. 2005; Liontos et al. 2007), while oncogene activation leads to oncogeneinduced senescence through p16INK4A and ARF (Braig and Schmitt 2006). Instead of
being distinct mechanisms, two groups recently found that oncogene-induced senescence
utilizes DNA damage repair mechanisms to elicit senescence in addition to p16INK4A and
ARF (Bartkova et al. 2006; Di Micco et al. 2006). These reports demonstrate that the
expression of activated oncogenes results in senescence that is dependent on both DNA
replication and DNA damage repair, and that inhibition of these processes inhibits the
observed oncogene-induced senescence. The expression of oncogenic Ras was shown to
directly lead to hyper-replication and increased replicon activation (Di Micco et al. 2006)
while the expression of other oncogenes, including mos, cdc6, and cycline E led to
senescence dependent on functioning DNA damage repair machinery, which is normally
activated as a consequence of double strand breaks reflective of re-replication and
genomic instability (Bartkova et al. 2006).

Together, these findings suggest that

oncogene overexpression induces re-replication and genomic instability. Such a result
could be due to increased preRC component expression as well as increased licensing of
preRCs.

Furthermore, several histone modifying enzymes have been shown to be

upregulated as a result of oncogene overexpression, which could lead to aberrant
chromatin access being granted and subsequent, improper MCM loading and preRC relicensing as we have shown chromatin fluidity to be a likely regulator of preRC
assembly. Activated Ras has been associated with increased Gcn5 and PCAF histone
acetyltransferase expression that is associated with the epithelial-mesenchymal transition
in carcinoma cells (Pelaez et al. 2010), while increased Her2 oncogene expression in
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certain breast cancer cells is associated with an increased copy number of the HBO1 gene
(Hu et al. 2009).
If the induction of the DNA damage repair pathway observed with oncogene
overexpression is indeed dependent on re-replication resulting from the generation of
improper chromatin access and preRC assembly, modulation of chromatin modifying
enzymes could result in inhibition or exacerbation of senescence. Reduction of proteins
that facilitate the creation of chromatin access, such as HATs, could potentially abrogate
the hyper-replication and senescence that accompanies activated Ras expression.

For

example, acute downregulation of HBO1 by RNAi along with Ras overexpression may
diminish the observed hyper-replication by DNA combing and senescence by SA-β-gal
staining compared to when control RNAi is used with Ras. Conversely, overexpression
of HBO1 with Ras could lead to increased levels of hyper-replication and increased
number of senescent cells. Furthermore, overexpression of HDAC11 with activated Ras
may serve to prevent or inhibit hyper-replication and subsequent induction of senescence.
Undertaking such experimental procedures that serve to correlate chromatin access with
oncogene-induced hyper-replication would add further support to the model in which we
propose chromatin fluidity as a mechanism of replication licensing.

Future Directions
The findings described here define a novel form of replication licensing involving
the generation of chromatin access by Cdt1 to facilitate MCM loading. This control is
mediated by two Cdt1-interacting enzymes: HBO1 and HDAC11. The mechanisms of
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control elucidated in this research project establish a new paradigm for Cdt1 function, but
many questions must still be answered in order to develop a thorough understanding of
this chromatin decondensation-based licensing mechanism. For instance, though HBO1
and HDAC11 are integral players in this Cdt1 driven chromatin remodeling, are other
histone modifying enzymes or ATP-dependent chromatin remodelers involved? By what
mechanisms does Geminin affect the Cdt1-HDAC11 interaction? What domains of Cdt1
are responsible for HDAC11 and HBO1 interaction?
disruption have on replication?

What effect does HDAC11

Further investigation is required to elucidate a more

complete and fluid comprehension of this novel mode of licensing.

Cdt1-Induced Remodeling and Histone Modifications
We have shown that histone H4 acetylation plays a role in Cdt1-mediated
chromatin decondensation (Fig. 37). While intriguing, it is unlikely that H4 acetylation is
the only modification on which chromatin remodeling at origins and MCM loading is
based.

Interestingly, we have found that a small proportion of Cdt1 opened HSRs

colocalizes with dimethylated histone H3 lysine 9.

This finding is important as it

suggests other histone modifications and other enzymes are likely involved in the
remodeling.

Furthermore, the methylation state of histone H3 is known to influence

HBO1 HAT complex binding, though not through H3K9 (Saksouk et al. 2009).

To

further our understanding of the histone modification status of Cdt1-induced remodeling,
we propose to utilize a broader panel of antibodies to modified histones to analyze in
conjunction with HSR decondensation.
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large-scale Cdt1-complex purification by affinity chromatography and liquid
chromatography, followed by tandem mass spectrometry analysis (Sugimoto et al. 2008).
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To identify other proteins modulating Cdt1-induced chromatin remodeling, it may be
prudent to perform such large-scale Cdt1 protein purifications in synchronized cell
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Seto 2009). As such, Cdt1 BiFC
purifications
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HA-YN-Geminin

fig16

in asynchronous populations may result in the dilution of important binding partners with
more short-lived interactions. Such a pursuit could serve to dissect out separate Cdt1containing complexes that exist during preRC licensing (i.e. G1) and after MCM loading
is actively suppressed (i.e. S-phase). This investigation has the potential to uncover other
chromatin modifying enzymes (i.e. histone methyltransferases, other HATs, etc.) or ATPdependent remodelers as active players in preRC licensing.

Cdt1 and Geminin-HDAC11
We have demonstrated that Cdt1, Geminin, and HDAC11 exist in a single, large
complex (Fig. 16) and that Geminin enhances the Cdt1-HDAC11 interaction (Fig. 15).
To further investigate the role of each protein in the dynamics of a large, multi-subunit
complex in vivo, we propose to utilize the Bimolecular Fluorescence Complementation
system (Hu et al. 2002), which involves tagging a protein of interest with half of the
enhanced yellow fluorescent protein (EYFP) and tagging a potential binding partner with
the other half of EYFP. Upon co-transfection, stably interacting proteins will bring the
two half tags within close proximity, thereby recapitulating the full length EYFP protein,
resulting in yellow fluorescence detectable by microscopy. We have generated functional
parental vectors based on this system and have demonstrated effective fluorescence
complementation between Cdt1 and Geminin (Fig. 41).
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Modulation of Cdt1 Function by HBO1 and HDAC11
We have shown that HBO1 and HDAC11 are crucial regulators of Cdt1dependent chromatin remodeling, and others have demonstrated the importance of HBO1
activity to replication licensing (Iizuka et al. 2006; Miotto and Struhl 2010). HBO1 and
HDAC11 both directly interact with Cdt1 (Glozak and Seto 2009; Miotto and Struhl
2010), however the precise domain or region of Cdt1 where these interactions take place
have yet to be clearly identified. To this end, we plan to perform co-immunoprecipitation
assays using full length HBO1 and HDAC11 with a panel of Cdt1 deletion mutants that
we have already generated (Fig. 43). We have analyzed these mutants in terms of their
ability to mediate chromatin unfolding (data not shown) and have found Cdt1 Δ201-355
to be dysfunctional in not only chromatin remodeling capability (Fig. 26), but also
impaired in its ability to maintain survival in long-term colony growth assays (Fig. 27)
and in its ability to stimulate re-replication (Fig. 28).

However, identifying specific

regions on Cdt1 responsible for HBO1 and/or HDAC11 binding represents an important
step in understanding the molecular basis of these interactions and the potential influence
other proteins (i.e. Geminin) may have in modulating them.
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Fig. 44 HDAC11 Specifically Blocks S-phase. HDAC1 or HDAC11 (or none) were
expressed for 24 hours in CHO cells. BrdU was pulsed for the last 30 minutes. BrdU
labeling indices were determined for each condition.

To further our understanding of HDAC11’s role in licensing control, it will be

important to examine the effects of HDAC11 enzymatic disruption on HDAC11

inhibition of Cdt1-induced chromatin remodeling, HDAC11 inhibition of Cdt1-induced
re-replication (Fig. 10), and HDAC11 inhibition of replication (Figs. 11&44).
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+

a catalytically dead HDAC11 mutant all represent viable methods by which to induce
HDAC11 dysfunction. If HDAC11 is an essential regulator of Cdt1 function, disrupting
this negative control could potentially result in a similar manner to overexpressing Cdt1
alone in each assay.

Overall, the field of replication licensing and G1-S control represent an important
avenue of basic cancer research, both in terms of understanding fundamental disease
biology and in the identification of potential drug targets. Precise coordination of the
events leading up to DNA replication initiation is absolutely crucial to maintaining
genomic stability. As such, multiple levels of control exist to regulate the cell cycle
machinery entrusted with copying the genetic information of a cell in its entirety, without
error. The complexity and the elegance of such a vital network of molecular signals is
awe-inspiring. As research in this field progresses, the details of this intricate regulatory
mechanism will slowly be revealed and I can only hope that the full scope of chromatin
fluidity-based regulation of replication licensing will be unearthed.
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